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ABSTRACT 
 Mycobacterium avium subsp. paratuberculosis (MAP) is the causative agent of 
Johne’s disease (JD), a chronic granulomatous enteritis of the small intestine of ruminants, 
taking many years for clinical symptoms to develop. Though primarily transmitted through 
ingestion of contaminated feces, MAP also can be transmitted through milk and colostrum. 
Unfortunately, many other microorganisms are present in milk along with MAP. Therefore, a 
decontamination protocol must be applied to the milk before culture. The objective of this 
research was to optimize a decontamination and culture protocol for the recovery of MAP 
from milk. The optimal protocol then was applied to milk and colostrum samples obtained 
from naturally infected dairy cows over complete 305-day lactation cycles to evaluate 
whether a correlation exists between stage in JD progression or point in lactation and the 
concentration of MAP shed into the milk. Studies found the most efficacious 
decontamination and culture protocol consisted of exposing milk to a solution of N-acetyl-L-
cysteine-1.5% sodium hydroxide for 15 min followed by inoculation into BACTEC 12B 
medium. When this protocol was applied to milk and colostrum samples collected from 
naturally infected dairy cows in various stages of JD, it was found that cows in more 
advanced stages had a higher likelihood of shedding MAP into milk and colostrum. MAP 
was also more likely to be isolated from milk samples taken within early lactation (0-60 days 
in milk). This study demonstrated that milk is a viable route of MAP transmission to calves, 
especially in early lactation when calves are most susceptible to infection and from cows 
with advanced stages of JD. Dairy producers should use this valuable information to change 
their calf-rearing practices to decrease the chances of disseminating MAP through their 
herds.  
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 CHAPTER 1: GENERAL INTRODUCTION  
Introduction 
 Johne’s disease is a ruminant wasting disease caused by infection with 
Mycobacterium avium subsp. paratuberculosis (MAP). Despite efforts to control the spread 
of JD, it is still a major source of lost revenue in the world’s dairy industry. It is known that 
MAP is shed into the milk and colostrum of infected cows and is therefore a viable route of 
transmission to calves. It is not known, however, whether the stage in MAP infection or point 
in lactation is correlated with the amount of MAP in milk and colostrum. Unfortunately, the 
current protocols for detecting viable MAP in milk are lacking sensitivity, so it is likely that 
the amount of MAP in milk is currently underestimated. Therefore, a sensitive protocol must 
be developed to detect viable MAP from milk and colostrum. The objectives of this study 
were to optimize decontamination and culture protocols for the maximal recovery of viable 
MAP while concurrently minimizing the amount of non-mycobacterial contaminants present 
in milk and to apply these protocols to milk from naturally infected dairy cows to investigate 
the potential correlation between stage in MAP infection and point in lactation on the amount 
of MAP shed into milk and colostrum.  
 
Thesis Organization 
 This thesis is organized into four papers intended for publication in peer-reviewed 
journals, along with a general introduction and conclusion. The general introduction, Chapter 
1, includes the rationale for this research project, objectives, and a comprehensive literature 
review. Chapters 2 and 3 are papers investigating the effects of decontamination and culture 
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protocols on the recovery of viable Mycobacterium avium subsp. paratuberculosis (MAP) 
from raw bovine milk. Chapter 4 is a study validating the efficacy of the optimal 
decontamination and culturing protocol concluded from the previous two chapters. Chapter 5 
explores the application of the optimal decontamination and culturing method on milk and 
colostrum samples from dairy cows naturally infected with MAP to determine any 
correlations between stage in lactation or stage in MAP infection with amount of MAP shed 
into the milk and colostrum. Finally, Chapter 6 provides a general conclusion and offers 
recommendations for future research.  
 
Literature Review 
Background 
 Mycobacterium avium subsp. paratuberculosis (MAP) is the causative agent of 
Johne’s disease (JD), also known as paratuberculosis. Johne’s disease was first discovered in 
1895 by Drs. H.A. Johne and L. Frothingham in Germany. Johne’s disease is a contagious, 
chronic granulomatous enteritis of the small intestine. Its primary hosts are domestic and 
wild ruminants, however, the bacteria have been isolated from other animals including 
carnivores, carrion-eating birds, and rodents (1).The 2007 National Animal Health 
Monitoring System (NAHMS) survey estimated the prevalence of Johne’s disease in U.S. 
dairy herds at ≥68%, whereas prevalence at the cow-level ranged from 1 to 20% (2, 3). With 
the large amount of animal trade that occurs around the world, it is thought that MAP is 
present in every country that utilizes ruminants as part of their agriculture base. The 
prevalence of JD differs between regions and countries, with the U.S. among the highest and 
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Norway and Sweden among the lowest.  It is estimated that the herd-level prevalence of 
MAP infection is higher than 50% in most countries with a large dairy industry (4). The 
North American beef industry reports herd-level prevalence between 7.9 and 43.8% (5, 6). 
The prevalence of JD in sheep and goats is much lower than that in cattle, with estimates 
between 0.3-3.5% (7).   
Johne’s disease causes significant monetary losses to the dairy industry. Typical 
monetary losses caused by JD are in the form of potential or unrealized revenue versus “out-
of-pocket” costs. In general, cows that test positive for JD, even if they are asymptomatic, 
produce less milk, are culled earlier, have a lower slaughter value, have increased calving 
intervals, and show more infertility (8, 9). In 2009, a study concluded that a JD-positive cow 
is worth $441 less than a negative cow over its lifetime (including slaughter value). This loss 
in value is a result of decreased milk production, increased mortality, and lower weight at 
culling. Positive cows had significantly lower lifetime milk production and 305-day milk 
production than did other cows. Over a complete lactation, lightly, moderately, and heavily 
infected cows produced on average 537, 1403, and 1534 kg, respectively, less milk (9). Cows 
with strong positive results were significantly more likely to be removed by 1 year after 
testing (10). A 2.5 kg/day decrease in 4% fat-corrected milk was observed in JD-positive 
dairy cattle, however, this decrease in production was not observed in the first lactation (11).  
The physical stress of MAP infection not only affects milk production but also fertility. 
Infected cows had a 28-day increase in days open compared to their negative cohorts (12). 
Cows which were MAP seropositive were associated with 1.4 times increased hazard of 
culling compared with MAP-seronegative cows (13). All of these health issues are most 
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likely associated with the negative energy balance caused by the manifestations of JD, 
costing the U.S. dairy industry $200-250 million annually (14). 
 
The MAP organism 
MAP is a Gram positive, rod shaped, acid-fast bacterium with a rough, thick, waxy 
cell wall. MAP is a member of the Mycobacterium avium complex (MAC). The MAC is 
comprised of several slow-growing mycobacteria (including M. avium subsp. avium, M. 
avium subsp. silvaticum, and M. avium subsp. hominissuis) that can be found in 
environmental, veterinary, and clinical settings. The MAC includes both opportunistic and 
professional pathogens of birds, animals, humans, and other organisms commonly found in 
water and soil (4). There are two major strains of MAP, Type I/III (S, typical in sheep 
infections) and Type II (C, typical of cattle infections). The two strains differ mainly in that 
the Type I/III strain is more fastidious and has a slower growth rate than does the Type II 
strain. Type I/III strain is thought to predominately infect sheep and goats, whereas the Type 
II strain has a broad host range of domestic and wildlife species including non-ruminants.  
The complete, annotated genome sequence of MAP strain K-10 was published in 
2005 (15). The 4,829,781 base pair sequence has 4,350 open reading frames. It is 
characterized to have a high proportion of guanine- and cytosine-containing nucleotides 
(69.3%) as well as an abundance of insertion sequences and PE/PPE proteins, a family of 
virulence proteins distinguished by Pro-Glu and Pro-Pro-Glu domains found only in 
mycobacteria. Subtyping of MAP is often based on two highly polymorphic short sequence 
repeats, the G residue repeat and GGT repeats (16). Recently, a comparison of the complete 
genomes of MAP S397 sheep and MAP K-10 cattle isolates showed that the ovine strain was 
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lacking two large regions that are present in the bovine strain. There were also seven large 
inversions between the two strains. The authors suggested that the bovine strain may have 
evolved from the ovine strain (17).  
MAP is an obligate pathogen of animals and does not exist in a replicative form in the 
environment.  It can survive in the environment for many months or even years where it is 
believed to form a spore-like morphotype and remain infective (18). MAP grows very 
slowly, with a generation time in liquid culture of 1.3 to 4.4 days that is inversely 
proportional to the inoculation size (19). Colonies often take 8-16 weeks to become visible 
on solid medium (20). MAP isolates often require an exogenous source of mycobactin, an 
iron siderophore, to grow in primary culture. MAP, unlike other mycobacteria, is unable to 
synthesize its own mycobactin, thus making it necessary to supplement the medium. The 
need for supplemental mycobactin was once used as an identifying feature to distinguish 
MAP from other mycobacteria but it is now unclear whether mycobactin is always necessary 
for the growth of MAP. Mycobactin dependence can be influenced by medium pH, iron 
concentration, and mycobactin carryover from primary medium as it is able to bind the cell 
wall of the bacteria (21). MAP is also resistant to heat treatment and can survive both high-
temperature, short-time pasteurization (72˚C for 15 seconds) and low-temperature 
pasteurization (63˚C for 30 min) if present in numbers greater than 101 (22-24). Heat 
treatment, however, causes a 4.0 to 7.7 log reduction in viable cells (25, 26). Survival is most 
likely the result of the clumping nature of the organisms attributed to the waxy composition 
of the cell walls (25). The fact that viable MAP remain after standard pasteurization is a point 
of concern to dairy producers and consumers.  
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Johne’s disease progression 
  The progression of JD is often very slow and affected animals do not show clinical 
symptoms until the final stages of the disease. Because of this, a diagnosis of the disease is 
very difficult and is often overlooked. In many cases, animals may be infected and spread the 
infection to other animals in the herd years before a diagnosis is made. It is estimated for 
every clinically confirmed case of JD there are another 25 infected animals that remain 
undiagnosed (27).  The progression of MAP infection from asymptomatic infection to 
clinical disease can be subdivided into four stages (27).  
Stage I is considered the silent infection. This stage is where the initial infection 
occurs by ingestion of MAP in contaminated feedstuffs, water, or milk, followed by uptake 
across the transepithelium of the small intestine, where it persists within subepithelial 
macrophages. MAP can enter the intestinal mucosa via specialized M cells in the epithelium 
lining the dome areas of Peyer’s patches, as well as via enterocytes (28, 29). MAP then 
slowly proliferates in the jejunal and ileal mucosa and spreads to the regional lymph nodes 
via infected macrophages (30). Fecal shedding of the bacteria at this stage of the infection is 
probable, but the quantity of MAP shed is often undetectable with the current detection 
methods.  
Stage II is the subclinical phase of the disease. At this point, there are higher 
concentrations of MAP in the intestinal tissues than stage I of the disease. These animals do 
not manifest any physical symptoms including weight loss or diarrhea. MAP is shed into the 
feces at a higher rate through sloughing of the infected intestinal epithelial cells into the feces 
(8). Because animals are asymptomatic, intermittent fecal shedding can unknowingly lead to 
contamination of the environment and possible infection of other cattle. Cattle may remain in 
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either stage I or II of infection for 2-5 years before progressing to clinical disease, whereas 
other animals may never develop clinical JD. There are no physical symptoms, so no 
indications are apparent to producers that the animal has the disease so no preventative 
actions are taken. Many times animals are culled at this stage of the disease for reasons that 
are not directly related to JD. Progression from stage II to stage III is highly variable and is 
influenced by many factors such as age and dose of initial exposure, frequency of re-
exposure, genetic factors of both the animal and organism, and environmental, nutritional, 
and production stresses (4).  
Stage III is the clinical phase. It is estimated that only 10-15% of infected animals 
will progress to clinical disease in their lifetime (31). Animals start gradually losing weight 
and have increasingly frequent bouts of diarrhea. Affected animals continue to have normal 
appetites and normal vital signs including body temperature. Emaciation and cachexia 
develop gradually, and milk production begins to wane. Fecal shedding is very high at this 
stage where the number of bacteria in the feces can exceed 10
8
 cells/g feces (8). 
Contaminated feces pose a major threat to surrounding animals. After developing severe 
clinical signs, cattle often are not retained in the herd for more than a week or two. The MAP 
population within intestinal cells of infected cows becomes very high and thickening of the 
intestinal mucosa and associated lymphadenopathy along much of the small intestine is 
present. This intestinal thickening leads to decreased absorptive capacity of the intestines, 
causing the characteristic weight loss. At this point, the infection becomes disseminated, with 
MAP being detectable in multiple extra-intestinal sites including supramammary, pulmonary, 
hepatic, and head lymph nodes. These cows are at higher risk of transmitting MAP in utero 
and also have a higher incidence of shedding into the milk (4). 
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The last stage, stage IV, is the advanced clinical disease. Animals have now become 
very weak and emaciated and have chronic profuse diarrhea. Bottle jaw becomes 
characteristic, which is caused by hypoproteinemia. The animal deteriorates very quickly and 
will die of dehydration and cachexia.  
 
Treatment 
There is no definitive cure for JD, but there are a number of therapeutic agents 
available to lessen or alleviate the clinical signs of JD. These include administration of 
antibiotics, immunomodulators, and probiotics (32). These resources should only be 
employed in cases where the animals are of significant economic, genetic, or sentimental 
value. Treatment must be maintained for the life of the animal and the animal will likely 
continue to shed MAP into the environment though likely at lesser numbers than an untreated 
animal. There are no drugs approved for the treatment of MAP infections, so any prescribed 
are done “extra label”. The most commonly used drugs to treat JD in ruminants are isoniazid, 
rifampin, and clofazimine. These drugs are also used in treatment of tuberculosis infections 
in humans and are most effective when given in combinations (32). The administration of 
these drugs is costly, so the decision to treat an animal must be carefully considered.  
 
Transmission 
There are three major modes of transmission of JD. The most common mode of 
transmission is fecal-oral. Because MAP has the ability to survive in the environment for 
long periods of time, oral contact with bedding, feed, or water that are contaminated with 
manure can easily result in the ingestion of viable MAP. Calves also can become infected by 
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suckling from a dam that has contaminated the outer surface of her teats with fecal material 
from an infected animal. Teats can become contaminated from improper cleaning of 
maternity pens between dams. MAP can also be transmitted in utero. Various studies 
estimated en utero MAP transmission rates to be between 11 and 40% in clinical cows, 18% 
in asymptomatic but “heavy shedding” cows, and rarely from “light shedders” (33, 34).  The 
final mode of transmission is shedding of MAP into the milk and colostrum of infected dams, 
leading to the infection of a susceptible calf.  
 
Dissemination of MAP to the mammary gland 
Dissemination of MAP to the mammary gland and lymph nodes is not fully 
understood. It is thought that once MAP is taken up by intestinal macrophages the infected 
macrophages can migrate to the mesenteric lymph nodes via the ductus thoracicus and 
ultimately to the bloodstream. The lymphatic uptake leads to the possibility of hematogenous 
or lymphatic spread of MAP (35). MAP has been detected in milk, blood, semen, and other 
extra-intestinal tissues such as the mammary lymph nodes (36-38). The bovine mammary 
gland can be considered a possible reservoir for the bacterium because MAP can be isolated 
from milk and colostrum of infected animals. One study found that the proportion of culture-
positive milk samples and supramammary lymph nodes was higher in animals that were 
heavily shedding MAP into their feces than the intermediate or light shedders (37). To 
further support this finding, lymph fluid was collected from superficial lymphatic vessels on 
the hind quarters of the udder from clinical, subclinical, and negative cows from herds with 
high prevalence of JD (39). The lymph fluid was positive for the MAP-specific genetic 
element IS900 by PCR in 66.7% of clinical cows, 42.8% of subclinical cows, and 38.7% of 
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negative cows. This study also indicated the plausibility of lymphatic dissemination of MAP 
via MAP-infected macrophages. Another study found MAP can be taken up by bovine 
mammary epithelial cells (the MAC-T cell line) from both the apical and basolateral surfaces 
(40). Exposure of MAP to milk and growth of MAP within MAC-T cells enhanced the ability 
of MAP to infect intestinal epithelial cells. High-osmolarity environments provided by both 
milk and the MAC-T cells caused a change in the gene expression of MAP that is associated 
with an invasive phenotype. All this evidence supports the hypothesis that MAP is spread 
systemically through the cow, it has the ability to infect and/or re-infect other cell types 
including foamy macrophages found within the mammary gland, and MAP infectivity may 
increase while in the mammary gland and within milk. Therefore, it is reasonable to believe 
that infected milk and colostrum are a viable route of transmission for neonates and young 
stock in herds that are infected with MAP.  
 
Susceptibility to MAP infection 
Neonates and young stock are most susceptible to MAP infection with resistance to 
infection increasing with age. A meta-analysis of studies found that calves less than 6 months 
of age had a 74% chance of becoming infected upon exposure to MAP, with likelihoods 
decreasing to 50% between 6 to 12 months of age and 19.3% in animals older than 12 
months (41). The mechanism for increased susceptibility in calves has not been determined, 
though it has been speculated that the “open gut” phenomenon in the first 24 hours of life 
may significantly aid in the invasion of MAP through intestinal uptake (42). In the first 24 
hours of life, macromolecules, such as immunoglobulins in the colostrum, are absorbed by 
pinocytosis. This mechanism could allow easier uptake of MAP through the intestinal 
11 
  
 
mucosa. Other hypotheses explain the phenomenon by immaturity of the neonatal innate and 
adaptive immune responses. Therefore, mature cattle have an improved ability to contain or 
eliminate the MAP organisms after they have penetrated the intestinal mucosa.  
 
Diagnostics 
Diagnostic techniques for JD are lacking sensitivity and/or specificity. There are two 
major classes of diagnostic procedures for JD: immune-based and microbiologic. The 
immune-based diagnostics can be split into two groups: serologic tests based upon measure 
of serum antibodies to MAP and tests based upon measure of antigen-specific, cell-mediated 
immune responses. The primary serologic assay is the enzyme linked immunosorbent assay 
(ELISA). This assay detects the presence of MAP antibodies in either milk or serum. ELISA 
is used commonly because of the ease of sample collection, rapid test results (one-day assay), 
and relatively low cost. The sensitivity of antibody detection in subclinically infected cows is 
estimated for serum and milk to be 24-94% and 21-61%, respectively (43). These estimates 
were collected from various studies that used different ELISA kits and protocols for sample 
collection and the assay. Therefore, a large range of sensitivities was reported. The cell-
mediated immune response tests include the interferon-gamma (IFN-γ) response test and an 
intradermal tuberculin test. The IFN-γ response test involves stimulation of a whole blood 
sample with MAP-specific antigen. If the host immune system has previously encountered 
MAP via exposure or infection, recall responses to MAP antigen will initiate IFN-γ 
production in vitro. Secreted IFN-γ then can be detected through an ELISA. The sensitivity 
of this assay is estimated to be between 13 and 85% in a subclinical cow (43). The 
intradermal tuberculin test involves injecting MAP-specific antigen under the skin and 
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measuring the area of the induration at the injection site 72 hours after injection. The 
presence of the induration indicates an apparent immune response. The estimated sensitivity 
of this test in sheep is 73% (44). The results from these tests, however, need to be interpreted 
with caution. Due to the long delay between infection and presentation of bacteria to the 
immune system in sufficient numbers to develop a detectable immune response, immune-
based tests can present false-negative results. Cows that have been vaccinated against JD also 
can elicit false-positive results (45).  
Fecal and tissue culture have been considered the “gold standard” for the diagnosis of 
JD because it proves viable and infectious bacteria are present in the suspected animal. Fecal 
culture is used more frequently to diagnose JD than tissue solely based on the ease of 
obtaining a sample. Intestinal tissues are frequently cultured post-mortem. The sensitivity of 
fecal culture for a subclinical cow is estimated to be 74% (43). Identification of MAP from 
culture should be based on phenotypic and genetic characteristics such as being acid-fast, 
growth characteristics including mycobactin dependency, as well as PCR confirmation of 
unique genetic elements such as IS900 (4, 46).The use of PCR to identify MAP-specific 
genetic elements will be further explored later in this review.  
 
Prevalence of MAP in milk 
Over the years, numerous studies have been published investigating the amount of 
MAP present in raw milk from individual cows, raw bulk-tank milk, pasteurized cow’s milk, 
and other milk products. To this day, a consensus has not been made on how much MAP is 
actually shed into the milk because of many confounding factors. These factors include but 
not limited to, variations in the locale and disease status of sampled herds and cows, 
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disparities in sampling protocols, and variations in diagnostic tests and protocols used. Also, 
MAP has proven to be a difficult organism for the development of reliable and sensitive 
diagnostic tests that causes further problems in correct interpretation of results.  
Because of inconsistencies in experimental protocols for the collection and culture of 
MAP from milk, there is a wide range of values presented in the literature. These 
inconsistencies make it difficult to estimate the true MAP load present in individual and bulk 
tank milk. By using methods as varied as culture on HEYM and LJ solid media, as well as 
IS900 and F57 PCR, the number of MAP reported in individual cow’s milk varied from 2-8 
cfu/50 ml to <100 cfu/ml to 10-560 cfu/ml (37, 47, 48). The proportion of culture positive 
milk samples was higher in heavy shedding asymptomatic cows (19%) than in intermediate 
(11%) or light shedder (3%) asymptomatic cows (37). When symptomatic cows were 
examined, 35% of milk samples were culture positive (49). These results suggest the 
likelihood of shedding MAP into milk is greater with more advanced disease. MAP also was 
more frequently isolated via culture on HEYM from colostrum samples (7.9%) than from 
milk samples (2.4%) taken from individual cows in a herd with high prevalence of JD (50).  
Numerous surveys have been completed to determine the prevalence of MAP in raw 
individual and bulk tank milk through culture- and PCR-based detection methods. Table 1.1 
is a summary of surveys separated by the source of the milk samples; positive individual 
animals and herds, unknown status animals, and bulk tank samples from positive and 
unknown status herds. In general, detection of MAP by PCR results in a higher prevalence 
than culture because of differences in sensitivity of the tests or because PCR detects both live 
and dead bacteria, whereas culture only detects live bacteria. Also, samples obtained from 
positive herds or animals seem to have a higher prevalence of MAP than samples obtained 
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from animals and herds with unknown status which lends to the hypothesis that MAP is shed 
in greater numbers in cows with more advanced disease.  
 With all the surveillance of MAP in milk that has been completed, one study is 
lacking. There have been no publications attempting to correlate the amount of MAP shed 
with the stage of disease and days in milk (DIM). The ultimate goal of this thesis is to 
determine if there are any patterns or correlations with the stage of disease and the DIM with 
the amount of viable MAP shed into the milk of individual cows that are well characterized 
for JD.  
 
Enumeration of MAP in Milk 
 Highly variable reporting about the prevalence of MAP in both individual and bulk 
tank milk samples exist, in part, because of discrepancies between culture and PCR detection 
methods. Two significant factors could be contributing to this discrepancy. First, PCR detects 
the presence of both live and dead bacteria. Therefore, the percentage of samples that contain 
viable MAP detected by culture methods may be lower than the percentage of samples that 
are detected by PCR. Also, because of the slow growth rate of MAP relative to other 
microorganisms present in milk, milk samples must be subjected to decontamination 
procedures prior to culturing in order to suppress the growth of non-mycobacterial organisms 
that are also present in raw milk such as yeast, molds, coliforms, Escherichia coli, 
Salmonella, and Listeria monocytogenes (51). Even though strides are made to not affect the 
viability of MAP, many, if not all, of the decontamination procedures do affect recovery of 
viable MAP to varying degrees. Also, the fastidious nature of MAP has made it difficult to 
find a medium that is well suited for its growth. It is possible that even if the viable organism 
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is transferred to the various growth media that it will not survive and replicate. Therefore, the 
combined effects of a decontamination protocol and the difficulty in culturing MAP may 
limit the number MAP-positive samples that can be detected through culture. 
 
Culture: decontamination and concentration techniques 
A number of factors are necessary to attain proper culture conditions for MAP.  These 
include decontamination techniques that will selectively kill non-mycobacterial flora that are 
present in the raw milk through the use of chemical and antibiotic treatments, concentrating 
specimens to increase the recovery of MAP from culture, and optimizing the culture medium 
to accommodate the fastidious nature of MAP. Decontamination is necessary because of the 
slow growth rate of MAP compared with that of many other microbes. Other microbes will 
often overwhelm the medium, which may starve the slower-growing MAP organisms of 
essential nutrients.  In addition, overgrowth by these microbes may thwart detection of MAP 
growth.   
There are a variety of chemical and anti-microbial treatments that have been explored 
to decontaminate specimens containing mycobacteria. The decontamination techniques take 
advantage of the resistance of mycobacteria to acids, bases, and other antibiotics because 
they possess complex, waxy cell walls (52, 53). Chemical decontamination is often used to 
prepare samples for culture of many mycobacterial species. The targeted specimens are 
mainly feces, tissue, sputum, or milk. Much of previous research has focused on isolation of 
MAP from feces and tissues, but little has focused on milk. All four specimen types are very 
different matrices and vary from each other both in terms of number and type of 
contaminating microorganisms present. They also vary on the number of MAP present in the 
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specimen. Feces typically has higher numbers of bacteria, as high as 10
8
 cfu/g (8), tissues 
typically harbor fewer, and milk even less with estimated levels equal to or less than 10 
cfu/ml. Therefore, achieving the highest level of sensitivity is a key consideration when 
developing a method for culture of MAP from milk to avoid false-negative results. The ideal 
chemical or chemical combination used for decontamination of samples would have no effect 
on the viability of the mycobacteria, yet still be capable of killing all contaminating 
microorganisms. 
Because of the relatively low concentrations of MAP in milk, steps must be taken to 
concentrate samples to maximize the possibility of recovering the organism from milk. The 
most common form of concentration is centrifugation. When milk is centrifuged it partitions 
into three fractions, cream, whey, and pellet. Within these fractions, MAP partitions 
primarily to the cream and pellet (54-56). One study using experimentally spiked milk 
samples demonstrated that the amount of MAP that partitions to the cream, whey, and pellet 
layers after centrifugation at 2,500 x g for 15 min is 13.0, 17.6 and 69.4%, respectively (54). 
Another study found that centrifugation of spiked milk at 3,100 x g for 30 min resulted in 3-
fold more MAP in the cream fraction than was recovered from the pellet (55). A third study 
investigated spiked milk and colostrum centrifuged at 974 x g for 36 min at 4˚C to separate 
the cream and then curdled the whey and centrifuged again at 974 x g for 5 min to recover 
the curd. They found that 19.8% of MAP partitioned to the cream, 0.003% partitioned to the 
whey, and 80.2% partitioned to the curd in milk (56). Similar values were obtained for 
colostrum with 19.7, 0.1, and 80.2% of MAP partitioning into the cream, whey, and curd, 
respectively. Similar fractioning of MAP in milk was observed even at centrifugation speeds 
of 41,000 x g (57). However, such high centrifugation speeds require specialized centrifuges 
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and tubes making it difficult for some laboratories to utilize this protocol. Because these 
studies have different milk separation protocols, it is difficult to directly compare the results. 
However, the conclusion that can be made from these studies is after centrifugation of milk 
or colostrum, both the pellet and cream should be harvested to maximize the recovery of 
MAP but the whey can be discarded.  
Another method of concentrating MAP in milk samples is immunomagnetic 
separation (IMS), a method that uses MAP-specific antibody-coated magnetic beads. IMS is 
able to recover MAP from milk at concentrations as low as 10 cfu/ml (54). However, IMS is 
only useful to determine presence or absence of MAP because of the clumping nature of the 
beads and the fact that more than one bacterium can bind to a bead. Therefore, actual 
quantification of MAP cfu cannot be determined when using IMS in combination with solid 
medium.  Also, the beads have a maximal binding capacity so they cannot capture all of the 
bacteria present in a sample if they are present in high numbers. It is also possible that 
contaminating (non-MAP) bacteria may bind to or be carried along with the beads so a 
chemical decontamination step may still be necessary for culture. Lastly, IMS beads are 
costly compared with centrifugation as a means for concentrating MAP in milk samples. For 
all these reasons, IMS is not readily used for MAP culture. 
Four chemicals are commonly used in mycobacterial decontamination assays: 
hexadecylpyridinium chloride (HPC), sodium hydroxide (NaOH), oxalic acid (OA), and 
benzalkonium chloride (BC). Even though there is a consensus on the use of these four 
chemicals, there exists much discrepancy about concentrations of each chemical, length of 
exposure time, the need for neutralization, preparation of the chemicals, and the combined 
use of chemicals. HPC and BC are quaternary ammonia compounds thought to perturb the 
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lipid bilayer membranes of microorganisms leading to generalized and progressive leakage 
of cytoplasmic materials (58). HPC is commonly the active ingredient in non-alcohol-based 
mouth washes, and BC is often the active ingredient in hard-surface disinfectants and first-
aid antiseptics (58, 59). NaOH and OA are lethal to contaminating microorganisms because 
they disrupt intracellular pH of the organism. Mycobacteria are able to maintain internal pH 
significantly better than non-mycobacterial organism (60). NaOH is often used in 
conjunction with N-acetyl-L-cysteine (NALC) and sodium citrate. NALC is a mucolytic 
agent that has the ability to reduce disulfide linkages within or between proteins (61) causing 
“liquefaction” of the sample to allow for better contact between the NaOH and the 
contaminating microorganisms and better partitioning of milk during centrifugation. Sodium 
citrate is thought to exert a stabilizing effect on the NALC because it chelates heavy metal 
ions that can oxidize NALC and render it useless (61). BC is often used in conjunction with 
trisodium phosphate (TSP) because it is also a mucolytic agent.  
Few experiments have been performed to investigate the optimal decontamination 
conditions for MAP and milk. Only three studies have reported comparison of different 
decontamination conditions for the recovery of MAP from milk. Most recently, comparisons 
were made between 0.75% HPC in either a water or half-strength Brain Heart Infusion (BHI) 
broth base, with exposure times between 2 and 48 hours (55).  HPC treatment was followed 
by incubation of milk samples in antibiotic cocktail consisting of 100 µg/ml vancomycin, 50 
µg/ml amphotericin B, and 100 µg/ml nalidixic acid (VAN) for time periods ranging from 0 
and 96 hours at room temperature. Results demonstrated that 0.75% HPC in water controlled 
contamination better than 0.75% HPC in BHI, though no difference was seen in the recovery 
of viable MAP. When exposure to HPC was increased from 5 to 24 hours, the number of 
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viable MAP cells decreased by 45%. Likewise, when exposure time to VAN was increased 
from 0 hours to 48 hours the number of viable MAP cells decreased by 42%.  Therefore, the 
optimal time of decontamination included incubation with 0.75% HPC between 2 and 5 
hours followed by inoculation onto the media immediately after resuspending the sample in 
VAN. Another study observed a decrease from 8/18 to 2/18 culture positive milk samples 
after being exposed to 0.75% HPC for 5 hours when compared with no chemical exposure 
(62). The milk samples were experimentally spiked with 10
6
-10
7
 cfu/ml of MAP and heat-
treated at 63°C for 20 minutes prior to decontamination and culture.  Lastly, a third group 
compared four decontamination procedures; 0.75% HPC for 5 hours at room temperature 
(RT), 0.75% and 0.9% HPC in half strength BHI overnight at 37˚C (known as the Cornell 
method), and a novel decontamination method that combined use of NaOH, C18-
carboxypropylbetaine (CB-18) – Tris-citrate buffer and NALC (63). The last procedure 
proved to be laborious and costly compared with the other three methods. Of these 4 
methods, it was concluded that treating milk with 0.75% HPC for 5 hours at RT was the 
superior method, resulting in a mean recovery of 28.7% and a detection limit of 30 cfu/40 ml 
milk. Multiple survey studies have used variations of the HPC decontamination methods, 
demonstrating that it has become the predominant decontamination protocol for milk (37, 49, 
50, 57, 64-71). 
Because the recovery of viable MAP from milk can be affected adversely by 
treatment with HPC and antibiotics, other chemicals and methods of decontamination need to 
be explored. The method of decontamination is particularly important because the low 
concentration of MAP naturally present in milk might be further diminished by these 
treatments, resulting in false-negative culture results. There is little insight to be drawn from 
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culturing of MAP from tissue and feces as HPC is most commonly used as the chemical of 
choice for these specimens. These protocols typically use 0.75 or 0.9% HPC incubated 
overnight at 37˚C and may or may not be followed by an incubation in antibiotic cocktail  for 
up to 72 hours at 37˚C. These protocols are estimated to cause a 2.7 log10 reduction in viable 
MAP (72) and have a detection limit around 10
4
 cfu/g feces (73). Therefore, decontamination 
methods used for other specimen types and mycobacterial species must be taken into 
consideration to find the optimal decontamination protocol. 
A study compared four chemicals or chemical combinations for their recovery of 
MAC from fecal samples; NALC-1% NaOH-sodium citrate, 0.5% HPC-1.0% NaCl, 2.5% 
oxalic acid, and 0.016% BC-12.5% TSP (53). They found the OA method yielded the 
greatest number of MAC cfu from seeded fecal samples. NALC-NaOH yielded a 2-fold 
decrease, BC yielded a 7-fold decrease, and HPC -NaCl yielded a 28-fold decrease in 
recovery as compared to OA. However, HPC-NaCl and BC-TSP had the lowest 
contamination rates. When comparing NALC-NaOH to OA treatment applied to clinical 
fecal samples, there was no difference in the number of positive samples detected. Therefore, 
this study concluded that both NALC-NaOH and OA are effective chemicals to use to 
decontaminate fecal samples containing MAC prior to culture on solid media such as 7H11 
and Lowenstein-Jensen. Another study investigated effects of various concentrations of four 
chemicals on recovery of Mycobacterium bovis suspended in tissue homogenates (74). They 
found the estimated percentage of surviving cells after treatment to be 70.6% in 0.25% BC, 
29.6% in 0.75% HPC, 34.1% in 5% OA, and 15.1% in 2% NaOH. The concentrations 
presented here were the recommended concentrations for the chemicals at the time of this 
publication. They found HPC to be the best chemical at controlling contamination, followed 
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by BC, OA, and, finally, NaOH. Therefore, they found HPC to be the superior decontaminant 
because it yielded the greatest number of surviving M. bovis along with the most effective 
control of contamination. Because of the design of this study, the results should be 
interpreted cautiously.  Samples were exposed to all of the chemicals for 30 min, which is 
contradictory to most other studies where exposure to detergent-type chemicals, HPC and 
BC, is on the order of hours and exposure to acid/base chemicals, OA and NaOH, is on the 
order of minutes. In addition, the researchers artificially contaminated the tissue specimens 
by rolling the tissue on laboratory floors or in soil samples. This action may have introduced 
flora that may not naturally be in a tissue sample, therefore, this method may not be fully 
applicable.  
The last set of studies to be explored investigated the use of NALC-NaOH on sputum 
samples for the recovery of M. tuberculosis (TB) and other mycobacterial species. In 1963, 
Kubica was the first to report that the addition of NALC to NaOH treatment allowed for the 
concentrations of NaOH to be reduced to one quarter to one half of the amount previously 
determined for sputum decontamination (75). The decrease in the amount of NaOH improved 
sensitivity for the detection of TB in clinical cases. It was found that NaOH concentrations 
should not be lower than 1.0% and exposure time should be at least 15 minutes to minimize 
contamination rates. Another study compared the use of NALC-NaOH and sulfuric acid on 
the recovery of mycobacteria from sputum (76). When comparing decontamination with 
NALC-1.7% NaOH and 3.0% sulfuric acid, they found sulfuric acid was more successful 
than NALC-NaOH for the recovery of TB but nontuberculosis mycobacteria were more 
susceptible to killing by NaOH. It was also found that both decontamination methods 
eliminated much of the contaminating bacteria and both reduced the viability of 
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mycobacteria in the specimen. The study did note a shift in the observed recovery of M. 
intracellulare and M. lentiflavum between the two chemicals showing that different species 
of mycobacteria react much differently to various decontamination methods.  This 
observation suggests that it is difficult to extrapolate chemical susceptibility across 
mycobacterial species. Another study comparing the use of NALC-1.0% NaOH and NALC-
1.25% NaOH in sputum samples for the recovery of mycobacteria found a 3% decrease in 
contaminated cultures and an 11% decrease in cultures positive for mycobacteria when 
1.25% NaOH was used versus 1.0% (77). They concluded that the small reduction in culture 
contamination was not justifiable at the expense of positive cultures. Lastly, a study 
examined whether increased NaOH concentrations and increased exposure times affected the 
viability of TB and contaminating bacteria (78). Within the NALC-NaOH protocol, 
concentrations of NaOH varied from 0.5-3.0% and time of exposure varied from 0 to 30 
minutes. They concluded that kill of contaminating bacteria was greatest at ≥1% NaOH and 
increased with time of exposure. Increased time of exposure did not affect the viability of 
TB, whereas increased concentrations of NaOH did. Conclusions from this study were that 
decontamination with 1-2% NaOH with an exposure time of ≥5 minutes was the optimal 
protocol to be applied to sputum samples for the recovery of TB.  
The use of NALC-NaOH methods may be just as applicable to the milk matrix. As 
with sputum, milk has a relatively high protein content and it too may inhibit the ability of 
the killing agent to contact the contaminating microorganisms. Although some studies show 
that NaOH is very detrimental to the viability of mycobacteria, other studies show there is 
large variation of susceptibility across species of mycobacteria (53, 74, 76). Therefore, the 
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NALC-NaOH method should be considered as a potential novel technique for the 
decontamination of milk for the recovery of MAP.  
As mentioned previously, antibiotic cocktails are frequently used as secondary 
decontamination of samples prior to media inoculation. They are also often added directly to 
media to suppress growth of any contaminating organisms that survived the chemical 
decontamination procedure. Commonly used antibiotics for mycobacteria include malachite 
green, cycloheximide, amphotericin B, vancomycin, nalidixic acid, polymixin B, 
chloramphenicol, penicillin G, trimethoprin, azlocillin, and ampicillin, though many of these 
have not been investigated for their potential to inhibit MAP growth (73, 79-81).  The most 
commonly used antibiotic cocktail contains 100 µg/ml vancomycin, 50 µg/ml amphotericin 
B, and 100 µg/ml nalidixic acid (VAN). When the effects of these antibiotics on MAP 
viability were investigated, it was found that threshold concentrations for decreasing the 
viability of MAP are 50 µg/ml for vancomycin and nalidixic acid, and 200 µg/ml for 
amphotericin B (82). Another study found a 24-hour exposure to VAN at standard 
concentrations after exposure to 0.75% HPC killed 42% of MAP cells in milk compared with 
samples subjected to the HPC treatment alone (55). These experiments show that antibiotic 
cocktails do influence the viability of MAP, and the effect may be compounded if it follows 
HPC treatment because of the damage and stress that HPC imposes upon MAP. It may be 
useful to investigate whether this same effect occurs after exposure to other chemicals, for 
example NALC-NaOH, or whether any specific antimicrobial agent affects the viability of 
MAP more than others. 
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Culture: media 
MAP has proven to be very challenging to effectively culture in a laboratory setting. 
Over the years, new media have been formulated and new technologies to detect the growth 
of bacteria have been developed. MAP growth media contains common essential nutrients 
such as casein digests, beef extracts, peptone, and essential element salts. Media is also often 
supplemented with egg yolk, mycobactin J, and antibiotics, as mentioned above, to 
discourage growth of contaminates. Egg yolk has been used to enrich media since 1912 (83); 
yet it is unclear why egg yolk is beneficial to the growth of MAP. We hypothesize that it is 
solely an enrichment that adds nutrients that are not found in simple media but may be most 
critical as a source of fatty acids. An egg yolk concentration of 3.3% in medium significantly 
improved the MAP recovery rate and time to detection when compared with media 
containing no egg yolk (84). It was also found that shaking of liquid culture reduced growth 
of MAP, a CO2 atmosphere was not required, and pH 6 was better for growth than higher pH 
(85).  
The common solid media used for the isolation of MAP are modified Herrold’s egg 
yolk medium (HEY), modified Lowenstein-Jensen medium (LJ), and modified Middlebrook 
7H10 and 7H11. HEY medium with mycobactin J is directly available from Becton-
Dickinson (BD), while LJ, M7H10 and M7H11 dehydrated media bases can be purchased 
from BD and necessary supplements added during preparation. HEY and LJ media contain 
egg yolk, malachite green, and antimicrobial agents in addition to the necessary nutrients 
present in basic broth media such as Middlebrook 7H10 and 7H11. All media require the 
addition of mycobactin J to support the primary isolation of MAP. Malachite green has broad 
spectrum antimicrobial activity as well as supplying a color contrast between the media and 
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the colonies of MAP (4, 86). Antibiotics like vancomycin, amphotericin, and nalidixic acid 
also are added to commercial media such as HEY. On solid agar media such as HEY and LJ, 
colonies of MAP initially appear as circular and glossy but as the cultures age the colonies 
will often adopt a rough appearance. Colonies are usually off-white in color, but pigmented 
isolates also have been identified. Because MAP is slow growing, solid media are allowed to 
incubate from 12-20 weeks for MAP isolation. MAP has a tendency to clump, so colony 
counts from solid media are a rough estimate of the actual number of bacteria present. Also, 
because agar slants do not accommodate much inoculum, multiple slants must be used for a 
single sample. 
There is a large range of liquid media available for the isolation of MAP. The basic 
broth medium is Middlebrook 7H9, and this serves as the base for each liquid medium 
system. The addition of egg yolk to media has proven to aid the growth of MAP. However, 
supplementation of liquid media with egg yolk causes them to become opaque disallowing 
use of optical densities as a measure of bacterial growth. Therefore, alternative methods have 
been developed to detect the growth of MAP. Currently, there are four liquid media systems 
for MAP available that allow for the addition of egg yolk, BACTEC 12B and MGIT 960 
(Becton Dickinson), ESP culturing system II (Thermo Fisher Scientific), and MB/BacT 
(BioMerieux). The BACTEC 12B medium is supplemented with C
14
-labeled palmitic acid. 
Bacterial growth results in respiration of C
14
-label carbon dioxide into the headspace of a 
sealed bottle. At regular intervals, the bottles of media are loaded into a semi-automated ion-
chamber reader, the BACTEC 460, which pierces the rubber septum with a sterile needle and 
samples the gas phase. The machine reports a number called a growth index (GI) which is 
calculated from the detected radioactivity. The BACTEC 12B medium is formulated for the 
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growth of TB, so egg-yolk, mycobactin J, and antibiotics must be added prior to its use for 
culture. This supplemented BACTEC 12B medium will be referred to as modified BACTEC 
12B from here on. The BACTEC MGIT 960 system detects a fluorescent signal from an 
indicator at the base of the culture vial. As oxygen is consumed during microbial respiration, 
the fluorescent signal increases until it reaches a detection threshold. The amount of egg yolk 
that can be supplemented into the media is limited because it interferes with detection of the 
fluorescent signal. The ESP culture system II monitors growth of microorganism by 
detecting a change in headspace pressure of the sealed bottle. This medium also contains egg 
yolk supplements to aid the growth of MAP. The MB/BacT system uses a colorimetric 
indication of carbon dioxide production. The BACTEC MGIT 960, ESP culture system II, 
and MB/BacT system all continuously monitor the growth in the bottles until a threshold 
change is obtained and the machines signal the bottles as positive. Because of the richness of 
liquid egg-based media, the addition of antibiotics is often used to suppress the growth of 
contaminating microorganisms. After any of the liquid media are flagged positive, formal 
identification of the microorganism by acid-fast stain and PCR is required to confirm the 
presence of MAP. 
Because of the large range of media available and a large range in cost, some research 
has focused on the identification of a superior medium for the growth of MAP. Many studies 
have demonstrated that the egg-yolk-based liquid media are superior to any solid media in 
respect to sensitivity of detection, time to positive, and genotypic selection (87-94). One 
study found liquid culture of the S strains of MAP was far more sensitive than culture on 
solid medium of similar composition. There were three times as many positive cultures in the 
modified BACTEC 12B medium than the solid M7H10 supplemented with mycobactin J. 
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Modified BACTEC  12B medium detected 94% of positive samples within 7 weeks of 
growth and colonies were visible on solid M7H10 within 14 weeks in 74% of positive 
samples (90).  
There have been fewer studies comparing the liquid media, most of which do not 
focus on the isolation of MAP. The ESP II medium was found to be similar in growth and 
detection of mycobacteria and ability to suppress contamination as the BACTEC MGIT 960 
medium (95). The ESP II medium had longer time to detection and had more false-positive 
samples than the BACTEC MGIT 960 medium. The BACTEC 12B medium grew M. 
tuberculosis complex isolates better than the ESP II medium and, conversely, the ESP II 
medium grew MAC isolates more efficiently than the BACTEC 12B medium (93). There 
was no difference in time to detection for these media, though there was a significant 
difference in rate of recovery of all isolates with averages of 89 and 79% for BACTEC 12B 
and ESP II media, respectively. In this study, the media were not supplemented with either 
mycobactin J or egg-yolk, so it was selecting against the growth of MAP. BACTEC 12B and 
BACTEC MGIT 960 media are similar in both detection sensitivities and time to recovery 
when evaluated for their ability to recover MAP from milk (96). The estimated sensitivity of 
detection for both media after HPC decontamination was 10
2
 cells/ml.  There was, however, 
no indication from the study of the ability of these media to suppress growth of contaminates. 
Another group formulated a liquid medium, Middlebrook 7H9+, that mimics the modified 
BACTEC 12B medium except that it does not contain 
14
C labeled palmitic acid (97). The 
limit of detection for this medium was 1 MAP cell/g of feces compared with 10
2
 MAP/g on 
solid media. Comparisons have not been made between all of the liquid media because of the 
high costs of the equipment necessary for the incubation and detection systems. Also, little 
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research has investigated which liquid media is superior for the detection of MAP in milk 
and suppression of contaminating microorganisms.  
 
Genetic detection of MAP 
The most common mechanism utilized to confirm the isolation of MAP is gene-
targeted PCR. MAP, like many other microorganisms, has unique genes. Currently, multiple 
gene targets have been developed including IS900, F57, ISMav2, hspX, and ISMap02 (98-
100). The IS900 element is the most commonly used target for MAP. MAP contains 15-20 
copies of the IS900 element within its genome. Although IS900 is only found in MAP, cross-
reactions with genes in mycobacterial relatives have been observed (101). This finding has 
invoked concern about potential false-positive reactions, prompting investigation into newer 
gene targets. The new gene targets can be useful to run multiplex PCR reactions.  
Although PCR can be used for direct detection of MAP from milk it is at a 
disadvantage when compared with culture because it cannot differentiate between viable and 
killed MAP. In addition, the milk matrix is known to substantially inhibit PCR. Contrary to 
what was originally believed, the high fat content is not the major inhibitor PCR. Instead, the 
high concentrations of calcium and the presence of plasmin in milk samples are the 
predominant interferences with the PCR reaction (102, 103). These both interfere with the 
function of the Taq polymerase. The calcium ions interrupt the interaction between the 
polymerase and the magnesium ion cofactors, and the plasmin degrades the polymerase 
protein. Recommendations to overcome the high calcium ions are to add magnesium ions 
directly to the PCR reaction or to physically chelate the calcium ions during DNA extraction 
or in the PCR reaction (102, 103). In addition, the plasmin presence can be diminished by 
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adding bovine serum albumin (BSA) or protease inhibitors to the PCR reaction or finding 
methods of removing all protein present in the DNA template solution (102, 103).  
Another major obstacle to overcome for efficient detection of MAP by PCR is that 
MAP is a difficult bacterium to lyse. Because MAP is present in very low numbers in milk, 
efficient lysis and recovery of the genomic DNA is critical. Bacterial lysis can either be 
performed chemically, mechanically, enzymatically, or combinations of the aforementioned 
methods. Two research groups have successfully formulated robust protocols for DNA 
isolation from milk with limits of detection between 1 and 10 cfu/ml using combinations of 
the three forms of lysis (104, 105). Both of these protocols use centrifugation to concentrate 
the MAP cells and extract DNA from only the pellet and cream. Other research has focused 
on the use of immunomagnetic beads to capture MAP from milk. In these cases, the IMS 
method is thought to be useful because the procedure theoretically removes all of the PCR 
inhibitors present in milk. Also, it is thought that IMS only captures intact cells, therefore, a 
larger proportion of the genomes detected by PCR are likely from intact viable cells when 
using this method as compared to other DNA extraction techniques. By using IMS, one study 
yielded a limit of detection of 10 or fewer organisms in 2 ml of milk (106). A commercial kit, 
ParaTub-SL
®
 Mycobacterium paratuberculosis IMS real time PCR kit, has been formulated 
by AnDia Tec
®
, but it is not available for purchase in the US. This kit is automatable and has 
a good detection limit, specificity, and reliability that consistently detects 20 or less MAP in 
1ml of milk (107). Even though these protocols have good detection limits, they might not be 
sensitive enough to detect the low concentration of MAP naturally present in milk of infected 
cows. It seems these protocols need to be altered to accommodate larger volumes of milk to 
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increase the likelihood of detection. It is obvious a robust and sensitive DNA isolation 
protocol is necessary for the detection of MAP in milk.  
 
Link to Crohn’s disease 
The last point that must be addressed is the possible association between MAP and 
Crohn’s disease (CD). For decades, there has been a debate in the scientific community as to 
whether MAP is also the causative agent of CD in human beings. Like JD, CD is an 
incurable, chronic, and progressive inflammatory bowel disease of humans. It is often 
characterized by severe abdominal pain, diarrhea, bowel obstruction, perforation, and fistula 
(108). These symptoms often impair the quality of life for the patients. In 1984, the isolation 
of MAP from intestinal tissues of patients with CD led to the suggestion that this organism 
may be the causative agent (8). Since then, MAP has been demonstrated to be present in 
intestinal tissues of CD patients at a higher frequency than those with ulcerative colitis and 
other control groups in many different studies (109-114). However, years after the initial 
isolation, there is still no definitive proof that MAP is the causative agent of CD. Currently, 
the hypothesis stands that a unique combination of genetic predisposition and environmental 
triggers results in immunologic dysregulation disorders (115, 116). The dysregulation causes 
a cascade of immunologic inflammatory mediators that results in hyper-responsiveness 
within the gastrointestinal tract, resulting in the clinical symptoms associated with CD and 
other inflammatory bowel diseases.  
The presence of lesions found in the intestines of CD patients that are typical of MAP 
infection are predominately explained by three theories: 1) an abnormally permeable mucosal 
barrier results in continuous translocation of commensal bacteria and/or their antigens into 
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the intestinal wall leading to chronic inflammation (117), 2) an imbalance between the 
protective and harmful intestinal bacteria leading to state of dysbiosis and chronic 
inflammation (118, 119), or 3) the existence of an unidentified persistent bacterial pathogen 
within intestinal tissues that drives the chronic inflammatory response (120). The first two 
scenario would allow for MAP to become an opportunistic pathogen and possibly increase 
the severity of the inflammatory response via antigens that elicit vigorous immunologic 
reactivity in humans (108, 121). In the third scenario, MAP could be the persistent bacterial 
pathogen that lurks in the intestine of the human host.  Because the presence of MAP is not 
measureable in every case of CD, this seems the least likely scenario.  The symptoms of CD 
are often controlled by antibiotics or by immunosuppressive drugs that aid in the control of 
dysbiosis by lessening the load of commensal bacteria present and by suppressing the 
inflammatory response. Whether or not CD is caused by MAP or whether it is a simple 
association remains to be elucidated. What is known, if MAP ultimately proves to be the 
causative agent of CD, there would be overwhelming consequences to the medical, 
pharmaceutical, agricultural, and veterinary industries. New chemotherapeutic agents, 
diagnostic procedures, and an intense JD control program would have to be identified and 
developed. If JD would ever be reclassified as zoonotic disease, it would be devastating to 
the world’s animal industries.  
 
Conclusion 
JD remains a costly disease to the dairy industry. Transmission of MAP through milk 
to neonates is a viable route for dissemination of JD within a herd. Much of recent research 
has focused on prevalence of MAP in milk, whereas little has focused on enumerating the 
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amount of viable MAP in milk. This lack of research is partially because of insufficient 
protocols for the detection and enumeration of viable MAP in milk, demonstrating the need 
for further research to optimize diagnostic procedures for isolation of MAP from the complex 
matrix of milk. Once a robust and sensitive protocol is formulated, it can be used to 
determine whether correlations exist between disease status and days in milk to the amount 
of MAP shed into milk. This information could lead to modification in dairy management 
practices, especially in feeding of bulk colostrum and waste milk to calves. It may also have 
implications to consumers of dairy products with the possible link to CD. 
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Table 1.1 Surveys of raw cow milk for the presence of MAP. 
Source of 
Samples
a Country 
No. 
Samples
b 
Type of 
Test
c 
No. 
Positive 
% 
Positive 
Reference 
Positive 
animals 
Denmark 11 
Culture-LJ 
& Dubos 
Broth 
5 46 (47) 
   PCR-IS900 2 18  
 United States 77 
Culture-
HEYM 
9 12 (37) 
 Australia 26 Culture-LJ 9 35 (49) 
Positive 
herds
d Canada 134 
Culture-
HEYM 
46 34 (64) 
   PCR-IS900 38 28  
   
PCR-nested 
IS900 
72 54  
 Argentina 24 
Culture-
HEYM 
2 8 (70) 
   PCR- IS900 0   
 Poland 87 
Culture-
HEYM 
2 2 (122) 
   PCR-IS900 18 21  
 United States 211 
Culture-
HEYM 
9 4 (66) 
   PCR-IS900 69 33  
 United States 126 
Culture-
HEYM 
3 2 (50) 
 
Czech 
Republic
 345
e
 
Culture-
HEYM 
0  (48) 
   
PCR-IS900 
or F57 
111 32  
 
Czech 
Republic 
483
f Culture-
HEYM 
15 3 (71) 
 
  
43 
  
 
Table 1.1 (Continued) 
Source of 
Samples
a Country 
No. 
Samples
b 
Type of 
Test
c 
No. 
Positive 
% 
Positive 
Reference 
Unknown 
animals 
Brazil 222 PCR-IS900 8 4 (123) 
 India 16
g Culture-
HEYM 
7 44 (124) 
   PCR-IS900 1 6  
 United States 1493 
Culture-
HEYM 
43 3 (67) 
   PCR-IS900 201 14  
Bulk milk- 
Positive 
herd
d 
United 
Kingdom 
244 
Culture-
HEYM & 
BACTEC 
12B 
4 2 (68) 
   
IMS-PCR-
IS900 
19 8  
 Austria 243 
Culture-
HEYM 
38 16 (107) 
   IMS-PCR
h 
47 19  
 Mexico 14 
Culture-
HEYM & 
LJ 
10 71 (125) 
   PCR-IS900 14 100  
 United States 52
i Culture-
HEYM 
0  (65) 
   PCR-IS900 35
j 
67  
Bulk milk- 
Unknown 
herds 
Ireland 389 Culture 1 >1 (69) 
   
IMS-PCR-
IS900 
50 13  
 Switzerland 100 PCR-F57 3 3 (126) 
 Iran 110 
PCR-nested 
IS900 
12 11 (127) 
 Denmark 143 PCR-IS900 19 13 (105) 
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Table 1.1 (Continued) 
Source of 
Samples
a Country 
No. 
Samples
b 
Type of 
Test
c 
No. 
Positive 
% 
Positive 
Reference 
 Cyprus 220 
Culture-
HEYM 
0  (128) 
   
PCR-IS900 
and F57 
63 29  
 Switzerland 1384 PCR-IS900 273 20 (129) 
a
Samples were from single animals, bulk containers on farm, or milk processing plants 
b
Each sample was subjected to all tests listed for the survey 
c
Tests that cultured for MAP used the specified media. Solid media consisted of Herrold’s 
egg yolk media (HEYM) and Lowestein Jensen medium (LJ). Liquid media consisted of 
Dubos broth and BACTEC 12B media. Tests that detected MAP genome used PCR or 
nested PCR. The gene of target is listed for each PCR test. Sometimes MAP was collected 
via immunomagnetic separation indicated by IMS. 
d
At least one seropositive or fecal positive animal 
e
Multiple cows sampled up to 5 times 
f
Samples were obtained from 3 herds, 2 JD positive and 1 JD negative 
g
Six samples possibly from more than one animal 
h
PCR tests were part of a commercial MAP detection kit with no specified PCR target 
i
52 herds sampled 3 times 
j
At least one of the 3 samples was positive 
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Abstract 
 Cows in advanced stages of Johne’s disease shed Mycobacterium avium subsp. 
paratuberculosis (MAP) into both their milk and feces, allowing for transmission of the 
bacteria between animals. The objective of this study was to formulate an optimized protocol 
for the isolation of MAP from milk and colostrum including parameters such as chemical 
decontamination with hexadecylpyridinium chloride (HPC) alone and in combination with 
antibiotics (vancomycin, amphotericin B, and nalidixic acid), and efficacy of solid, Herrold’s 
egg yolk medium (HEY), and liquid, BACTEC 12B and para-JEM, media. For each 
experiment, raw milk samples from a known Johne’s disease-free cow were inoculated with 
10
2
-10
8
 CFU/ml of live MAP.   Results indicated that increasing time of exposure to HPC 
from 5 to 48 hours, as well as increasing concentration of HPC from 0.75 to 1.50% decreased 
the recovery of viable MAP for all culture media.  Additional treatment of milk samples with 
antibiotics following HPC decontamination decreased the recovery of viable MAP more than 
did treatment with HPC alone. The BACTEC 12B medium proved to be the superior medium 
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for isolating MAP from milk by having a lower rate of contamination and threshold of 
detection than did either the para-JEM or HEY media. The optimal decontamination protocol 
determined was treatment of milk samples with 0.75% HPC for 5 hours at room temperature.  
This study demonstrated the efficiency of the recovery of MAP from milk is highly 
dependent upon the culturing protocol, and such protocols should be optimized to ensure that 
low concentrations of MAP in milk can be detected. 
 
Introduction 
 The progression of Johne’s disease (JD), a chronic granulomatous enteritis of the 
small intestine, is very slow, taking many years for clinical symptoms to manifest in the host 
(1). Mycobacterium avium subsp. paratuberculosis (MAP) is transmitted primarily through 
ingestion of contaminated feces where the number of bacteria can exceed 10
8
 cells per gram 
of feces, but MAP also can be transmitted through milk and in utero (2). In the later stages of 
JD, MAP can disseminate throughout the body and has been isolated from milk, 
supramammary lymph nodes, and lymph fluid from the udder (3-5). Calves that are fed 
maternal colostrum are more likely to become infected with MAP than those that are fed 
colostrum replacer or pasteurized colostrum, indicating raw colostrum and milk may be the 
initial point of exposure for neonates (6, 7). Studies have enumerated the amount of MAP 
shed into milk to be as low as 2-8 CFU/50 ml and as high as 10-560 CFU/ml (3, 8).  
Currently, the best method for detection of viable MAP is via culture. Unfortunately, 
the culture of MAP from milk presents many difficulties because of the slow growth rate of 
MAP compared with that of other microorganisms present in milk, the fastidious nature of 
MAP, and the low numbers of MAP naturally present in milk from infected cows. Therefore, 
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a sensitive culture protocol must be developed to detect the low concentrations of MAP 
present in milk. The basic procedure for isolation of MAP from milk includes centrifugation 
to concentrate the MAP, chemical decontamination, often with hexadecylpyridinium chloride 
(HPC),  to decrease the presence of contaminating microorganisms, and culture in either 
liquid or solid media optimized for the recovery of MAP. Protocols for the isolation of MAP 
from milk vary significantly, and a comprehensive study to find the most efficacious set of 
parameters for the isolation of MAP from the complex milk matrix is lacking (3, 9-17).  
Media most commonly used for the culture of MAP from milk include BACTEC 12B, para-
JEM, and Herrold’s egg yolk (HEY) (15, 18-20). These media vary greatly in composition, 
including the presence of growth supplements and antibiotics, as well as growth detection 
methods and therefore will vary in ability to grow MAP (21-23). It is unknown which, if any, 
of the media are superior at culturing MAP from milk.   
The objectives of the current study were to examine various conditions for the 
isolation of MAP from raw milk including effects of HPC decontamination and antibiotic 
treatment on the viability of MAP, the effect of centrifugation speed on the recovery of 
MAP, and evaluation of liquid and solid culture media for the ability to support and 
accurately detect the growth of MAP and suppress the growth of other microorganisms.  
 
Materials and Methods 
Milk. Milk used in these experiments was obtained from a Johne’s disease-free cow 
in a small dairy herd maintained at the National Animal Disease Center (NADC, Ames, IA). 
The noninfected control cows were originally purchased from herds with no recent history of 
JD and their status was validated by repeated negative fecal cultures for MAP
 
performed 
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biannually over a 5-yr period. In addition,
 
cows in the noninfected herd were negative on any 
serologic assays (i.e., production
 
of antibody specific for MAP and
 
IFN- ) performed during 
that period. All procedures performed on the dairy cows were approved by the Institutional 
Animal Care and Use
 
Committee (NADC).  Milk from the donor cow was hand stripped into 
sterile collection containers after thorough disinfection of the udder and teats with iodine teat 
dip and 70% ethanol.  Large volumes of milk were collected and stored at -80˚C until use. 
For each individual experiment, one container of milk (volume = 1 L) was thawed at 4˚C and 
gently mixed prior to execution of the experiment.  
Bacteria preparation.  Milk was experimentally spiked with MAP strain 167 that 
was obtained from a clinical cow housed at the NADC.  A frozen aliquot of MAP strain 167 
was inoculated into 450 ml of Middlebrook 7H9 broth (Becton Dickinson, Franklin Lakes, 
NJ) supplemented with 50 ml of oleic acid, albumin, dextrose, and catalase enrichment 
(OADC; BD), mycobactin J (2 mg/l; Allied Monitor, Fayette, MO), and 1.5 ml Tween 80 
(Sigma-Aldrich, St. Louis, MO) and cultured at 39˚C until it reached logarithmic growth 
phase (OD540nm = 0.2-0.4). The cultures were centrifuged at 10,000 x g for 30 min to pellet 
the bacteria. Pellets were washed twice with phosphate-buffered saline (PBS, 1 mM; pH 7.4; 
Sigma-Aldrich), and then resuspended in 10 ml of PBS. The suspension was sonicated 
briefly with a sonic disruptor to break up any clumps of bacteria (40 watt, three -10 sec 
intervals; Tekmar, Mason, OH).  The OD540nm was measured, and the suspension was diluted 
to achieve an OD of 1.15, corresponding to 10
9
 CFU/ml. Aliquots of the final suspension 
were frozen at -80°C.  For each of the experiments, an aliquot of bacterial suspension was 
thawed and the suspension was serially diluted in PBS (10
3
 to 10
9 
CFU/ml).  Then, 100 µl of 
each dilution was inoculated onto Herrold’s egg yolk medium slants (BD) containing 
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mycobactin J (2 µg/ml), amphotericin B (50 µg/ml), nalidixic acid (50 µg/ml), and 
vancomycin (50 µg/ml) and incubated at 39˚C for 12 weeks.  Colonies on the slants were 
counted every 4 weeks during the 12-week incubation period.   
Inoculation of milk.  For each experiment, triplicate samples of 18 ml milk and 2 ml 
of the respective dilution of bacterial suspension were prepared to yield final MAP 
concentrations of 10
2
, 10
4
, 10
6
, and 10
8 
CFU/ml of milk. A positive control consisted of 10
6 
CFU of MAP/ml in PBS, and a negative control consisted of milk with no bacteria.  A no-
treatment control consisted of 10
6 
CFU of MAP/ml of milk and was not subjected to the 
chemical treatment.  Each of these controls also was prepared in triplicate. Each sample was 
subjected to the basic milk processing protocol with single variables changing between 
experiments. Within each protocol, the samples (20 ml) were centrifuged at 1,865 x g for 30 
min at 4˚C to partition the milk unless otherwise specified. The whey layer was discarded, 
and the cream and pellet layers were retained for the experimental procedure.  
Temperature during HPC decontamination.  Effects of temperature were explored 
by comparing room temperature (RT, 22-25°C) and 39°C incubation during exposure of 
samples to HPC (Sigma-Aldrich) (Table 1).  Triplicate spiked milk samples were centrifuged 
as previously described, and the cream and pellet were resuspended in 5 ml of 1.05% HPC 
(0.75% final concentration).  Samples were incubated for 5 hr at either RT or 39°C. Tubes 
were centrifuged at 1,865 x g for 30 min at 4°C, and the pellets were resuspended in 1 ml of 
PBS for inoculation of the media. 
HPC concentration and exposure time.  Five ml of HPC in concentrations of 1.05, 
1.40, 1.75, and 2.10% were added to each prepared tube (Table 1). The tubes were briefly 
vortexed to resuspend the pellet and cream layers, yielding final concentrations of HPC of 
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0.75, 1.00, 1.25, and 1.50%.  Tubes were incubated at RT for 5, 24, and 48 hr.  Following 
this, tubes were centrifuged at 1,865 x g for 30 min at 4˚C. The chemical layer was 
discarded, and the cream and pellet were resuspended in 1 ml of PBS for inoculation of the 
media.  
Centrifugal force.  Effects of centrifugal force on the recovery of MAP from milk 
were determined by comparing speeds of 1,865, 3,500, and 5,600 x g (Table 1). Triplicate 
spiked milk samples were centrifuged as previously described, and the cream and pellet were 
decontaminated with 0.75% HPC for 5 hr at RT. Tubes were centrifuged at 1,865, 3,500, or 
5,600 x g for 30 min at 4°C. The chemical layer was discarded, and the cream and pellet 
were resuspended in 1 ml of PBS for inoculation of the media. 
Addition of antibiotics for decontamination.  The milk samples were spiked in 
triplicate with MAP to final concentrations of 10
2
, 10
4
, and 10
6 
CFU/ml. Positive and 
negative controls (as described above) also were used. Samples were decontaminated by 
using the protocol optimized in aforementioned experiments with 0.75% HPC for 5 hr at RT 
(Table 1). After centrifugation at 1,865 x g, replicate samples from each decontamination 
procedure were either resuspended in 1 ml of an antibiotic solution containing 100 µg/ml 
vancomycin (Sigma-Aldrich), 50 µg/ml amphotericin B (Sigma-Aldrich), and 100 µg/ml 
nalidixic acid (Sigma-Aldrich), also referred to as VAN, or 1 ml of PBS.  Samples 
resuspended in VAN were incubated overnight at 39˚C and then inoculated into media.  
Samples resuspended in PBS were inoculated into media immediately.  In addition, each 
antibiotic was evaluated individually in combination with HPC decontamination.  Milk 
samples were prepared as described above, but after centrifugation at 1,865 x g, samples 
were resuspended in 1 ml of PBS and inoculated into media immediately; or resuspended 
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into either 1 ml of an antibiotic solution containing 100 µg/ml vancomycin (V), 100 µg/ml 
nalidixic acid (N), or 50 µg/ml amphotericin B (A), or 1 ml of a solution containing all three 
antibiotics at their respective concentrations (VAN).  Samples treated with antibiotics were 
incubated overnight at 39˚C before inoculating into media. 
Media for recovery of MAP.  Two liquid culture media, BACTEC 12B and para-
JEM, and one solid medium, HEY, were compared for the ability to recover MAP from 
spiked milk samples.  The BACTEC 12B medium (BD) was supplemented with 0.5 ml of 
sterile unmodified raw egg yolk (in-house), 0.2 ml PANTA Plus (BD), 0.1 ml of 50 µg/ml 
mycobactin J, and 1.2 ml sterile deionized water. Each bottle was inoculated with 200 µl of 
decontaminated milk sample and placed in a 37˚C incubator. The growth index (GI) of the 
microorganisms in the bottles was measured by the BACTEC 460 Machine (BD) twice per 
week for the first 2 weeks and then once per week for the following 10 weeks. The bottles 
were considered positive when the GI reached 300, and then they were removed from 
incubation. At the end of the 12-week (84 days) incubation period, all bottles were subject to 
MAP growth confirmation. The para-JEM medium, (Thermo Fisher Scientific (TREK 
Diagnostic Systems, Inc.), Cleveland, OH) was supplemented according to the 
manufacturer’s instructions. Each bottle was inoculated with 500 µl of decontaminated milk 
sample and placed into the ESP Culture System II machine for up to 65 days according to the 
manufacturer’s instructions. When the ESP Culture System II machine signaled a positive 
bottle and indicated a positive growth curve, the bottle was removed for MAP growth 
confirmation. At the end of the incubation period, all bottles were subjected to MAP growth 
confirmation procedures noted below. Before media were removed from the bottles for 
growth confirmation, the bottles were shaken on a VXR IKA Vibrax shaker (IKA® Works, 
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Inc., Wilmington, NC) for 2 min to dislodge the MAP from the sponges in the bottles. MAP 
recovery from milk also was evaluated on HEY medium and compared with both liquid 
media. HEY medium was inoculated with 100 µl of decontaminated milk sample. The slants 
were allowed to incubate at 39˚C for 12 weeks. The colonies were counted at 4, 8, and 12 
weeks post-inoculation.  
MAP growth confirmation.  A Ziehl-Neelsen acid fast stain was performed on all 
bottles subjected to MAP growth confirmation. One drop of Acid Fast Mycohold™ Cell 
Adhesive (Wescore, Inc., South Logan, UT) was placed onto a microscope slide. About 100 
µl of sample was added to this slide and mixed thoroughly with the Mycohold™. The slides 
were allowed to air dry and then were fixed in 100% methanol for 15 min. Then, slides were 
stained with a standard Ziehl-Neelsen stain followed by methylene blue counter stain. DNA 
was extracted from samples for confirmation by PCR by incubating 500 µl of sample with 
100 µl of proteinase K (10 mg/ml; Qiagen, Germantown, MD) at 56˚C overnight in an orbital 
water bath, followed by centrifugation at 15,000 x g for 15 min to separate the fractions of 
the sample. The supernatant was removed, and the pellet was resuspended in 175 µl of PBS. 
DNA was extracted from the pellet using the MagMAX Total Nucleic Acid Isolation Kit 
(Life Technologies Corporation, Carlsbad, CA) protocol on the MagMAX Express machine 
(Life Technologies) as directed by the manufacturer. The extracted DNA was assayed for the 
presence of MAP by using real-time PCR with the MAP-specific IS900 target. Primer and 
probe sequences for IS900 were as follows: 200 nM forward primer 5’-
CCGCTAATTGAGAGATGCGATTGG-3’, 200 nM reverse primer 5’-
AATCAACTCCAGCAGCGCGGCCTCG-3’, and 100 nM probe 5’-
TCCACGCCCGCCCAGACAGG-3’ with a 5’ fluorescent FAM label and a 3’ TAMRA 
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quencher (Integrated DNA Technologies, Coralville, IA). The qPCR was conducted in an 
Applied Biosystems 7500 Fast Real-Time PCR System (Life Technologies) by using 
TaqMan® Fast Advanced Master Mix (Life Technologies). Each qPCR reaction plate also 
contained a standard curve ranging from 10
 
fg/µl to 1 ng/µl that was generated from MAP 
strain K10 genomic DNA, no-template negative controls, and positive controls of MAP strain 
19698 genomic DNA.  Amplification conditions were as follows: stage 1: 95˚C for 20 sec, 
stage 2: 94˚C for 3 sec and 66˚C for 30 sec repeated for 40 cycles. All samples with a 
threshold cycle (Ct) less than or equal to 37 were considered positive. MAP growth was 
confirmed on the HEY medium slants by colony morphology and slow-growing 
characteristics. All colonies were compared with those present on the positive control sample 
slants. If any unusual colonies appeared, confirmatory protocols as stated above were 
performed.  
Classification of final culture results.  The final interpretation of positive or 
negative status of each milk sample after culture is shown in Table 2.  A sample was 
classified as positive if both the AF and PCR results confirmed the positive signal from the 
machine.  If the machine signaled positive but AF and PCR confirmatory tests were negative, 
the sample was considered either contaminated or false positive, depending upon the 
presence of non-MAP microorganisms. Samples were classified as negative if the machine 
signal was negative and both the AF and PCR confirmatory tests were negative.  A sample 
was considered a false negative if the AF and PCR results were both positive, following a 
negative machine signal. 
Statistical analysis.  Statistical analysis was performed by using the GLIMMIX 
procedure of the Statistical Analysis System (SAS Institute, Cary, North Carolina, USA). The 
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model included the fixed effects of treatment (concentration of HPC, time, temperature, 
centrifugation speed, culture medium, and antibiotics), sample (spiked milk), and treatment x 
sample interaction. When significant effects (P<0.05) due to treatment, sample, and 
treatment x sample interaction were detected, least square means separation were computed 
by Tukey-Kramer post-hoc test.   
 
Results 
 Effects of temperature during HPC decontamination of milk samples prior to culture 
were examined.  A typical HPC decontamination protocol described in the literature and 
previously performed in our laboratory (0.75% HPC for 5 hr) was used as a scaffold to 
perform the evaluation of temperature effects (9-11).  In the present study, HPC 
decontamination was performed at either RT or 39°C, but neither temperature had a 
significant effect on MAP recovery (P=0.63, data not shown). Increasing the temperature 
from RT to 39°C during decontamination of milk samples increased the contamination rates 
from 15.6% to 31.1% in BACTEC 12B medium and 33.3% to 42.2% in para-JEM medium.  
 The results of the effects of HPC concentration and time of exposure on the recovery 
of MAP from experimentally inoculated raw milk cultured in BACTEC 12B and para-JEM 
media are shown in Figures 1 and 2, respectively. Data from milk samples inoculated with 
10
8
 CFU of MAP/ml are not shown for simplicity. For both media, higher concentrations of 
HPC resulted in significant reductions (P < 0.05) in the recovery of viable MAP.  Similarly, 
increasing the time of exposure to HPC from 5 to 48 hrs also decreased (P < 0.01) the 
viability of MAP, regardless of culture medium. Differences in time to recovery were more 
noticeable when lower concentrations of MAP (10
2
 CFU/ml) were examined, especially for 
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samples cultured in BACTEC 12B medium (Figure 1A). These effects were not observed 
when milk was cultured in the para-JEM medium, as the majority of the samples were 
machine negative at the end of the 65-day incubation period (Figure 2). Inoculation of milk 
with higher concentrations of MAP (10
4
 and 10
6
 CFU/ml) was suggestive of the 
susceptibility of MAP to HPC, but effects of HPC concentration and temperature of exposure 
were not as clearly demonstrated as for lower inoculum concentrations (Figures 1B/C and 
2B/C). There was no correlation between concentration of HPC or time of exposure with 
rates of contamination in cultured samples. Overall contamination rates were 2.8% (data not 
shown), regardless of medium or treatment. The majority of contamination occurred in 
samples that were decontaminated for 48 hours with HPC. This increase in contamination 
suggests that longer incubation of milk samples in HPC may be selecting for HPC-resistant 
organisms. Pseudomonas species are known to have intrinsic and acquired resistance to 
quaternary ammonium compounds like HPC (24). Interestingly, we encountered 
Pseudomonas species as a common contaminate in our cultures as well.  
 The three media tested, BACTEC 12B, para-JEM, and HEY, differed considerably in 
the efficiency of recovering MAP from decontaminated milk samples. The results clearly 
demonstrated that HEY medium was inferior to the liquid media in recovery of MAP from 
milk, with limits of detection estimated to be 10
4
 CFU/ml. Our results were comparable to 
another study using HPC decontamination prior to culture on HEY medium (9). Therefore, 
no further analyses using HEY medium were conducted. BACTEC 12B medium consistently 
recovered lower concentrations of MAP and did so faster (P<0.01) than did the para-JEM 
medium (Figure 3).  BACTEC 12B medium recovered milk samples spiked with the lowest 
concentration of MAP (10
2
 CFU/ml) 14 days earlier than the para-JEM medium, even 
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though the volume of inoculum added was 2.5-fold greater for para-JEM bottles than for 
BACTEC 12B bottles. BACTEC 12B medium failed to recover only 3% of the milk samples 
spiked with 10
2
 CFU/ml of MAP, whereas para-JEM medium failed to recover 71% of 
samples spiked at this concentration. Also, para-JEM medium triggered erroneous false 
positive or negative machine indications with 11.6% of samples, an effect that was not 
observed in experiments with BACTEC 12B medium.  
Increasing centrifugation force from 1,865 to 5,600 x g did not enhance the recovery 
of MAP from milk samples from any of the three media (P=0.45, data not shown). A slight 
reduction in time to recovery was observed as centrifugal force was increased. Further, there 
was no effect of centrifugal force on contamination rates for the samples. Interestingly, 
increased force aided in the ease of handling the milk sample by increasing the fractionation 
of the milk into cream, whey, and pellet. 
 Overnight incubation of the milk samples with the antibiotic cocktail, VAN, after 
decontamination with HPC resulted in detrimental effects on the recovery of viable MAP 
(Figure 4). There was an increase (P < 0.01) in the time to recovery after secondary treatment 
with VAN when compared with HPC alone, regardless of liquid medium used or 
concentration of the MAP inoculum. Treatment with VAN doubled the time to recovery from 
33 to 70 days for milk samples spiked with 10
2
 CFU/ml of MAP and incubated in BACTEC 
12B medium. This effect was not observed for samples inoculated into para-JEM medium as 
10
2
 CFU/ml was close to the threshold of detection for this culture system. The additional 
treatment with VAN did decrease contamination rates for milk samples inoculated into para-
JEM medium to non-detectable levels.  No improvement was observed with VAN treatment 
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of samples when culturing with BACTEC 12B medium, as contamination rates were already 
negligible.   
 Exposure of MAP in milk samples to any of the three antibiotics or the combination 
had a negative effect to the viability of MAP regardless of inoculum concentration (Figure 
5). Exposure to any singular antibiotic (V, A, or N) or the cocktail (VAN) caused a consistent 
decrease in viability in both culture media. All decreases were statistically significant 
(P<0.05) except for the effects of amphotericin B in BACTEC 12B medium that only had a 
tendency (P=0.17) to decrease viability.  
 
Discussion 
This study examined the effects of various HPC decontamination and culturing 
parameters on the viability of MAP. We demonstrated that the efficiency of the recovery of 
MAP from milk is highly dependent upon the culturing protocol, and care should be taken to 
ensure that low concentrations of MAP in milk are being detected. Protocols for culturing of 
MAP should be balanced to include conditions that will control the growth of contaminating 
microorganisms and yet remain minimally lethal to MAP.  
Physiologic temperatures are often used for HPC decontamination in culture 
protocols for the recovery of MAP from fecal samples, with the ideology being that the 
increased temperature will stimulate the bacteria to become metabolically active and allow 
the HPC to impart a more detrimental effect on the contaminating microorganisms (16, 17). 
In the present study, decontamination of milk samples at 39°C (body temperature of a cow) 
resulted in increased rates of sample contamination.   In addition, decreases in MAP viability 
have been observed in with higher temperatures in previous studies, although a decrease was 
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not observed in the present study (9).  These results suggested that decontaminating samples 
at physiological temperature was not beneficial for optimal recovery of MAP from raw milk.  
 Although HPC is known to have detrimental effects on MAP it is still the most 
commonly used chemical decontaminant to treat samples prior to culture of MAP. Similar to 
our results, a study found that increases in HPC exposure time did not decrease the 
concentration of contaminating microorganisms in the milk samples (9). This study, 
however, only examined the effects of one concentration of HPC (0.75%) on the recovery of 
viable MAP and the presence of contaminating microorganisms. In the present study, 
treatment of milk samples with 1.50% HPC, a concentration that is 2 times greater than 
values proposed in the literature, did not completely contain contamination (3, 9-17). The 
detrimental effects of increased concentrations of HPC as well as increased exposure times 
observed in the present study were not compensated for by a decrease in contaminating 
microorganisms as contamination rates were relatively low in the present study. Therefore, 
the recommended protocol for chemical decontamination of milk to maximize the recovery 
of MAP in culture was determined to be 0.75% HPC for 5 hr at RT. Although HPC is 
perhaps the most widely used chemical decontaminant for culture of MAP, other chemicals 
need to be explored for potential improvements to the limits of detection.  
 Various media proved to have largely different abilities to support and detect the 
growth of MAP from milk. HEY medium proved to be far inferior to the two liquid media, 
with a sensitivity of detection estimated at 10
4 
CFU/ml of MAP. In addition, there were 
technical issues after inoculation of processed milk samples onto the agar slants of the HEY 
medium.  The thick layer of milk often inhibited accurate counting of MAP on the slants. In 
some cases, it was difficult to distinguish between MAP colonies and milk fat globules, and, 
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in other cases, the colonies were entirely masked by the thick layer of inoculum. Also, the 
manual task of counting the colonies was more time consuming than the automated nature of 
the liquid medium systems.  
 Though the BACTEC 12B and para-JEM media performed dramatically better than 
HEY medium, there were still marked differences in abilities of these two media to recover 
low concentrations of MAP from milk samples. The BACTEC 12B medium consistently 
recovered MAP from milk samples spiked with 10
2
 CFU/ml of MAP whereas para-JEM 
medium did not. The BACTEC 12B medium consistently detected lower inoculation 
concentrations, had faster detection times, and had fewer incidence of machine indicated 
false positive and negative samples. These differences are the result of media formulation as 
well as methods used by the culture systems to detect MAP growth.  
One major difference in medium supplementation between the two liquid media was 
the addition of fresh raw egg yolk to the BACTEC 12B medium, whereas factory modified 
egg yolk was added to the para-JEM medium as per manufacturer’s protocol. Because of the 
proprietary nature of the para-JEM medium, it is not known exactly what factory 
modifications were made to the egg yolk supplement. Differences in egg yolk freshness 
could lead to differences in the ability to support MAP growth because fatty acids, a major 
component in egg yolk lipids, have limited shelf lives. The availability of abundant fatty 
acids in egg yolk may help MAP recover any damage incurred during the decontamination 
process. In fact, growth of mycobacteria in the presence of free fatty acids causes changes in 
the morphology and increases the lipid content of the cells (25). Secondly, different 
antibiotics were added to each medium, which could potentially affect the viability of MAP.  
The manufacturer of the BACTEC 12B medium recommends the use of PANTA PLUS, 
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which consists of polymixin B, amphotericin, B, nalidixic acid, trimethoprim, and azlocillin. 
It also contains polyoxyethylene stearate, which is a non-ionic emulsifying agent that aids in 
the dispersal of the bacteria and of free fatty acids present in the medium to allow for better 
nutrient uptake (26). The para-JEM medium contains the same antibiotics as the VAN 
cocktail. Notably, the BACTEC 12B medium does not contain vancomycin. Vancomycin is 
known to be detrimental to the viability of MAP as demonstrated by a 28-49 day increase in 
the time to detection when vancomycin (86 µg/ml) was added to the BACTEC 12B medium 
(27). The para-JEM medium also contains a reagent called para-JEM
®
 BLUE. This reagent 
is used to minimize baseline drift to prevent false positive signals but also has been shown to 
retard the growth of MAP by increasing times to detection by up to one week when 
compared with para-JEM medium not supplemented with para-JEM
® 
 BLUE (28). The 
addition of para-JEM
®
 BLUE may also be contributing to the decreased ability for para-
JEM medium to recover low levels of MAP from milk. 
The methods of detecting growth in each medium are also quite different. The 
BACTEC 12B medium relies on detection of radioactive carbon dioxide evolved by the 
bacteria after oxidizing 
14
C-labeled palmitic acid. This method is sensitive and very reliable, 
though the issues of purchasing, handling, and disposing of radioactive material must be 
dealt with. For these reasons, the manufacturer recently has decided to discontinue this 
product. In contrast, the ESP culture system II relies upon a decrease in headspace pressure 
of the bottle as its detection method. This method is much less precise leading to incidence of 
false positive and negative signals. Collectively, the BACTEC 12B medium achieved results 
that were superior to the para-JEM medium in regards to both detection thresholds and time 
to detection. 
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Antibiotic cocktails are frequently used in conjunction with chemical decontaminants 
to control growth of contaminating microorganisms during culture. The most commonly used 
antibiotic cocktail for mycobacterial culture contains 100 µg/ml of vancomycin and nalidixic 
acid and 50 µg/ml of amphotericin B (VAN) (9, 16, 17). Other studies have noted that use of 
VAN in these concentrations can be detrimental to the viability of MAP, with the suggestion 
to decrease the concentrations of vancomycin and nalidixic acid to 50 µg/ml (9, 29). Yet, in 
these two studies, there were no comments on how the lower concentrations of these 
antibiotics might affect their ability to inhibit the growth of contaminating microorganisms. 
In the present study, VAN exposure had detrimental effects on the viability of both MAP and 
contaminating microorganisms. The lethal effects of VAN observed may be compounded 
because treatment followed exposure to HPC. HPC can damage the MAP bacterium and may 
cause MAP to become more vulnerable to the antibiotics to which it is normally resistant. 
The marked decrease in numbers of viable MAP is not a reasonable accommodation for the 
decrease in contaminants, especially when the goal was to determine a protocol able to detect 
low concentrations of MAP present in milk. When the components of the VAN cocktail were 
assessed individually, similar detrimental effects were observed for each individual antibiotic 
as well. It was surprising to find that amphotericin B affected the viability of MAP, as it is an 
anti-fungal agent thought to have little effect on the viability of bacteria. It is speculated that 
vancomycin might be a major factor delaying the growth of ovine strains of MAP compared 
with bovine strains when it was supplemented into growth medium (27).  Further studies 
should investigate whether different antibiotics would have similar effects on MAP or 
whether decreasing the concentration of each antibiotic in the cocktail would decrease the 
detrimental effects observed for VAN on MAP in this study.  
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In conclusion, we recommend decontaminating raw milk with 0.75% HPC for 5 hours 
at room temperature to maximize the recovery of MAP from raw milk while minimizing the 
amount of contaminating microorganisms. BACTEC 12B medium is the superior media 
because it has the lowest limit of detection and fastest time to detection. Although BACTEC 
12B medium is no longer commercially available, hopefully other products will be 
forthcoming that will be show comparable efficacy on the recovery of viable MAP from 
milk. The ability to accurately assess shedding of MAP into milk of naturally infected cattle 
will provide critical information to producers about the risk of transmitting MAP to calves 
via consumption of milk from infected cows.  
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Table 2.2. Classification of the final status of each milk sample based upon machine 
indication, acid-fast stain and IS900 PCR results. 
 
Machine Indicator Acid-Fast (AF) IS900 PCR Interpretation 
Positive Positive Positive Positive 
Positive 
Negative or 
Non-AF organisms present 
Negative Contaminated 
Positive Negative Negative False Positive 
Negative Negative Negative No Growth 
Negative Positive Positive False Negative 
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Figure 2.1. Time to recovery of Mycobacterium avium subsp. paratuberculosis in raw milk 
spiked with 10
2
 – 106 CFU/ml  after treatment with 0.75, 1.00, 1.25, and 1.50% 
hexadecylpyridinium chloride (HPC) for 5, 24, and 48 hours in BACTEC 12B medium. Data 
are expressed as means ± SEM, n=3: A) 10
2
 CFU/ml; B) 10
4
 CFU/ml; C) 10
6
 CFU/ml. 
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Figure 2.2. Time to recovery of Mycobacterium avium subsp. paratuberculosis in raw milk 
spiked with 10
2
 – 106 CFU/ml  after treatment with 0.75, 1.00, 1.25, and 1.50% 
hexadecylpyridinium chloride (HPC) for 5, 24, and 48 hours in para-JEM medium. Data are 
expressed as means ± SEM, n=3: A) 10
2
 CFU/ml; B) 10
4
 CFU/ml; C) 10
6
 CFU/ml. 
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Figure 2.3. Comparison between the BACTEC 12B and para-JEM media for time to 
recovery and detection sensitivity of Mycobacterium avium subsp. paratuberculosis in raw 
milk spiked with 10
2
 – 108 CFU/ml. Data are expressed as means ± SEM, n=36.  Significant 
differences between the two media are represented by asterisks (**P < 0.01).  
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Figure 2.4. Effects on the speed of recovery of Mycobacterium avium subsp. 
paratuberculosis in milk cultured in BACTEC 12B and para-JEM media after treatment with 
the antibiotic cocktail (VAN) consisting of 100 µg/ml vancomycin (V), 50 µg/ml 
amphotericin B (A), and100 µg/ml nalidixic acid (N) compared with treatment alone with 
hexadecylpyridinium chloride (HPC). Data are expressed as means ± SEM, n=3.  Significant 
differences between HPC alone or HPC plus VAN within each medium are represented by 
asterisks (**P < 0.01; *P < 0.05). 
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Abstract 
 Mycobacterium avium subsp. paratuberculosis (MAP) is shed into milk and feces of 
cows with advanced Johne’s disease, allowing transmission of MAP among animals. The 
objective of this study was to formulate an optimized protocol for the isolation of MAP from 
milk. Parameters investigated included chemical decontamination with N-acetyl-L-cysteine-
sodium hydroxide (NALC-NaOH), alone and in combination with antibiotics (vancomycin, 
amphotericin B, and nalidixic acid), and efficacy of solid, Herrold’s egg yolk medium 
(HEY), and liquid, BACTEC 12B and para-JEM, culture media. For each experiment, raw 
milk samples from a known noninfected cow were inoculated with 10
2
-10
8
 cfu/ml of live 
MAP. Results indicate increased length of exposure to NALC-NaOH from 5 to 30 min and 
increased concentration of NaOH from 0.5 to 2.0% did not affect the viability of MAP. 
Additional treatment of milk samples with the antibiotics following NALC-NaOH treatment 
decreased the recovery of viable MAP more than treatment with NALC-NaOH alone. The 
BACTEC 12B medium was the superior medium of the three evaluated for isolation of MAP 
from milk, with the fastest and most reliable detection of growth. Treatment of milk samples 
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with NALC-1.50% NaOH for 15 min, followed by culture in BACTEC 12B medium was 
determined to be the optimal conditions for milk decontamination and culture. This study 
demonstrates that the severity of the detrimental effect of chemical decontamination on the 
recovery of viable MAP is highly dependent upon the chemical(s) used and the sample 
matrix. Therefore, it is important to optimize milk decontamination protocols to ensure low 
concentrations of MAP can be detected.  
 
Introduction 
 Mycobacterium avium subsp. paratuberculosis (MAP), the causative agent of Johne’s 
disease (JD), is transmitted primarily through ingestion of contaminated feces but can also be 
transmitted through milk and in utero (1, 2). As the infection progresses, MAP can 
disseminate throughout the body and has been isolated from milk, supramammary lymph 
nodes, and lymph fluid from the udder (3-5). Contaminated colostrum or milk may be 
consumed by highly susceptible neonates and youngstock, leading to possible infection with 
MAP and persistence of JD within a herd. Studies enumerating the amount of MAP shed into 
milk have reported concentrations between <1 and 560 cfu/ml (3, 6). A meta-analysis of 
MAP in milk found the prevalence of MAP in bulk tank milk samples collected from known 
infected herds and herds of unknown status was 6% and 1%, respectively, as detected by 
culture, and 68% and 22%, respectively, as detected by IS900 PCR (7).  The discrepancies in 
prevalence between culture and PCR detection methods may be because PCR detecting both 
live and dead bacteria, whereas culture only recovers viable microorganisms. Also, bulk tank 
milk is contaminated with dirt during milking from the exterior of the teats which could 
contribute to high PCR prevalence because MAP DNA has been detected in settled dust 
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collected from the housing barns (8, 9). Therefore, PCR prevalence may not be reflective of 
actual MAP shedding, whereas, culture is a direct measure of transmissible MAP.  
Because current PCR assays have not been developed to decipher between viable and 
non-viable MAP, culture must be used to enumerate MAP present in milk. Unfortunately, the 
culture of MAP from milk presents many difficulties because of the organism’s slow growth 
rate and fastidious nature, as compared with other organisms present in milk. Therefore, a 
decontamination and culturing protocol must be developed that will thwart growth of more 
rapid-growing microorganisms present in raw milk, allowing time for detection of low 
concentrations of MAP that are naturally present in milk. Hexadecylpyridinium chloride 
(HPC) is the common chemical of choice for milk decontamination prior to culture, even 
though it has been shown to decrease the viability of MAP (10-13). Therefore, other 
chemicals need to be investigated for their effects on the recovery of viable MAP in 
conjunction with their ability to decrease the presence of other contaminating 
microorganisms. The chemical combination consisting of N-acetyl-L-cysteine-sodium 
hydroxide (NALC-NaOH) is primarily used for sputum decontamination for the isolation of 
M. tuberculosis (14). The mucolytic agent, NALC, is useful as a liquefying agent for samples 
with high protein content as it reduces disulfide bonds in proteins and allows for application 
of lower concentrations of NaOH (15). Like sputum, milk has a high protein content, so 
NALC-NaOH decontamination also may be applicable to the milk matrix.  
In conjunction with decontamination protocols, the medium used for culture of MAP 
has an impact on the sensitivity of MAP detection in milk. In a recent study, the BACTEC 
12B medium was found to be the superior medium for culturing MAP from milk after 
decontamination with HPC (Bradner, unpublished data). Because it is not known whether the 
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chemical used for decontamination had an influence on this outcome, the same commonly 
used media, BACTEC 12B, para-JEM, and Herrold’s egg yolk (HEY), were evaluated for 
their efficacy to recover MAP in the present study (16-18).  
The objectives of this study were to examine the effects of treatment of raw milk 
samples spiked with MAP with NALC-NaOH and antibiotics on the recovery of viable MAP.  
In addition, liquid (BACTEC 12B and para-JEM) and solid (HEY) media were compared for 
the ability to support and accurately detect the growth of MAP and suppress the growth of 
other microorganisms.  
 
Materials and Methods 
Milk. Milk used in these experiments was obtained from a healthy cow (without JD) 
in a small dairy herd maintained at the National Animal Disease Center (NADC, Ames, IA). 
The noninfected
 
control cows in the herd were characterized by repeated fecal cultures
 
negative for MAP performed biannually over a 5-yr period and had been purchased from 
herds with no recent history of Johne’s disease. In addition, these animals were negative on 
any serologic assays (i.e., production
 
of antibody specific for MAP and
 
IFN- ) performed 
during that period. All procedures performed on the animals were approved by the 
Institutional Animal Care and Use
 
Committee (NADC, Ames, IA).  Milk from the cow was 
hand stripped into sterile collection containers after thorough disinfection of the udder and 
teats with iodine teat dip and 70% ethanol.  Large volumes of milk were collected at one time 
and stored at -80˚C until use. For each individual experiment, one container of milk (volume 
= 1 L) was thawed at 4˚C and gently mixed prior to execution of the experiment.  
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Bacteria preparation.  Milk was experimentally spiked with MAP strain 167 that 
was obtained from a clinical cow housed at the NADC.  A frozen aliquot of MAP strain 167 
was inoculated into 450 ml of Middlebrook 7H9 broth (Becton Dickinson, Franklin Lakes, 
NJ) supplemented with 50 ml of oleic acid, albumin, dextrose and catalase enrichment 
(OADC; BD), mycobactin J (2 mg/l; Allied Monitor, Fayette, MO), and 1.5 ml Tween 80 
(Sigma-Aldrich, St. Louis, MO) and cultured at 39˚C until it reached logarithmic growth 
phase (OD540nm = 0.2-0.4). The cultures were centrifuged at 10,000 x g for 30 min to pellet 
the bacteria. Pellets were washed twice with phosphate-buffered saline (PBS, 1 mM; pH 7.4; 
Sigma-Aldrich) and then resuspended in 10 ml of PBS. The suspension was sonicated briefly 
with a Tekmar sonic disruptor to break up clumps of bacteria (40 watt, three 10-sec intervals; 
Tekmar, Mason, OH).  The OD540nm was measured, and the suspension was diluted to 
achieve an OD of 1.15, corresponding to 10
9
 cfu/ml. Aliquots of the final suspension were 
frozen at -80°C in snap-cap tubes.  For each of the experiments, an aliquot of bacterial 
suspension was thawed and the suspension was diluted serially in PBS (10
3
 to 10
9 
cfu/ml).  
Then, 100 µl of each dilution was inoculated onto Herrold’s egg yolk medium slants (BD) 
containing mycobactin J (2 µg/ml), amphotericin B (50 µg/ml), nalidixic acid (50 µg/ml), 
and vancomycin (50 µg/ml) and incubated at 39˚C for 12 weeks.  Colonies on the slants were 
counted every 4 weeks during the 12-week incubation period.   
Inoculation of milk.  For each experiment, triplicate samples of 18 ml milk and 2 ml 
of the respective dilution of bacterial suspension were prepared to yield final MAP 
concentrations of 10
2
, 10
4
, 10
6
, and 10
8 
cfu/ml of milk. A positive control consisted of 10
6 
cfu 
MAP/ml in PBS, and a negative control consisted of milk with no bacteria.  A no treatment 
control consisted of 10
6 
cfu of MAP/ml milk and was not subjected to the chemical 
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treatment.  Each of these controls also was prepared in triplicate. Each sample was subjected 
to the basic milk processing protocol with single variables changing between experiments. 
Within each protocol, the samples (20 ml) were centrifuged at 1,865 x g for 30 min at 4˚C to 
partition the milk. The whey layer was discarded, and the cream and pellet layers were 
retained for experimental procedure.  
Preparation of NALC-NaOH solution. Equal volumes of 2.9% sterile sodium 
citrate (Sigma-Aldrich; NaOH, Mallinckrodt, St. Louis, MO) and 4 times the final 
concentration sterile NaOH (Sigma-Aldrich) were mixed. Immediately prior to use, N-acetyl-
L-cysteine (NALC, Sigma-Aldrich) was added to yield a concentration of 0.5%. Note the 
NALC and sodium citrate concentrations were held constant regardless of the NaOH 
concentration. 
NALC-NaOH concentration and exposure time. The cream and pellet layers were 
resuspended in PBS to a final volume of 5 ml. Then, 5 ml of NALC-NaOH solution 
containing 1.0, 2.0, 3.0, or 4.0% NaOH was added to the tubes and briefly mixed, yielding 
final NaOH concentrations of 0.50, 1.00, 1.50, and 2.00%. The tubes were incubated for 15 
min at room temperature (RT, 22-25°C).  Immediately after the incubation, 15 ml of PBS 
were added to dilute the NaOH and then centrifuged at 1,865 x g for 30 min at 4°C. The 
chemical layer was discarded, and the cream and pellet were resuspended in 1 ml PBS for 
inoculation of the media. To investigate the effects of exposure time, the same protocol was 
performed except 5 ml of NALC-2.0% NaOH solution was added to samples yielding a final 
concentration of 1.0% NaOH. Samples then were incubated for 5, 15, or 30 min at RT. 
Addition of antibiotics for decontamination. The milk samples were spiked in 
triplicate with MAP to final concentrations of 10
2
, 10
4
, and 10
6 
cfu/ml. Positive and negative 
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controls (as described above) also were used. Samples were decontaminated by using the 
protocol optimized in aforementioned experiments with NALC-1.5% NaOH for 15 min at 
RT. After centrifugation at 1,865 x g, replicate samples from each decontamination 
procedure were either resuspended in 1 ml of an antibiotic solution containing 100 µg/ml 
vancomycin , 50 µg/ml amphotericin B, and 100 µg/ml nalidixic acid (VAN) or 1 ml of PBS.  
Samples resuspended in antibiotic solution were incubated overnight at 39˚C and then 
inoculated into media.  Samples resuspended in PBS were inoculated into media 
immediately.   
Media for recovery of MAP. Two liquid culture media, BACTEC 12B and para-
JEM, and one solid medium, HEY, were compared for the ability to recover MAP from 
spiked milk samples.  BACTEC 12B medium (BD) was supplemented with 0.5 ml of sterile 
unmodified raw egg yolk (in-house), 0.2 ml PANTA™ (BD), 0.1 ml of 50 µg/ml mycobactin 
J, and 1.2 ml sterile deionized water. This supplemented medium will be referred to as 
BACTEC 12B medium. Each bottle was inoculated with 200 µl of decontaminated milk 
sample and placed in a 37˚C incubator. The growth index (GI) of microorganisms in the 
bottles was measured by the BACTEC 460 Machine (BD) twice per week for the first 2 
weeks and then once per week for the following 10 weeks. The bottles were considered 
positive when the GI reached 300 and then were removed from incubation. At the end of the 
12-week (84 days) incubation period, all bottles were subject to MAP growth confirmation. 
The para-JEM medium (Thermo Fisher Scientific (TREK Diagnostic Systems, Inc.), 
Cleveland, OH) was supplemented according to the manufacturer’s instructions. Each bottle 
was inoculated with 500 µl of decontaminated milk sample and placed into the ESP Culture 
System II incubator for up to 65 days according to the manufacturer’s instructions. When the 
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bottles signaled positive and indicated a positive growth curve, the bottles were removed for 
MAP growth confirmation. At the end of the incubation period, all bottles were subject to 
MAP growth confirmation procedures noted below. Before medium was removed from the 
bottles for growth confirmation, the bottles were shaken on a VXR IKA Vibrax shaker 
(IKA® Works, Inc., Wilmington, NC) for 2 min to dislodge the MAP from the sponges in 
the bottles. MAP recovery from milk also was evaluated on HEY medium (BD) and 
compared with both liquid media. HEY medium containing mycobactin J and VAN was 
inoculated with 100 µl of decontaminated milk sample. The slants were allowed to incubate 
at 39˚C for 12 weeks. The colonies were counted at 4, 8, and 12 weeks post-inoculation. 
MAP growth confirmation. A Ziehl-Neelsen acid fast stain was performed on all 
bottles subject to MAP growth confirmation. One drop of Acid Fast Mycohold™ Cell 
Adhesive (Wescore, Inc., South Logan, UT) was placed onto a microscope slide. About 100 
µl of sample was added to each slide and mixed thoroughly with the Mycohold™. The slides 
were allowed to air dry before fixing in 100% methanol for 15 min. Then slides were stained 
with a standard Ziehl-Neelsen stain followed by methylene blue counter stain.  DNA was 
extracted from samples for confirmation by PCR by incubating 500 µl of sample with 100 µl 
of proteinase K (10 mg/ml; Qiagen, Germantown, MD) at 50˚C overnight in an orbital water 
bath, followed by centrifugation at 15,000 x g for 15 min to separate the fractions of the 
sample. The supernatant was removed, and the pellet was resuspended in 175 µl of phosphate 
buffer from the MagMAX™ Total Nucleic Acid Isolation Kit (Life Technologies 
Corporation, Carlsbad, CA).  DNA was extracted from the pellet using the protocol provided 
by the kit on the MagMAX™ Express machine (Life Technologies) as directed by the 
manufacturer. The extracted DNA was assayed for the presence of MAP using real-time PCR 
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with the MAP-specific IS900 target. Primer and probe sequences for IS900 were as follows: 
200 nM forward primer 5’-CCGCTAATTGAGAGATGCGATTGG-3’, 200 nM reverse 
primer 5’-AATCAACTCCAGCAGCGCGGCCTCG-3’, and 100 nM probe 5’-
TCCACGCCCGCCCAGACAGG-3’ with a 5’ fluorescent FAM label and a 3’ TAMRA 
quencher (Integrated DNA Technologies, Coralville, IA). The qPCR was conducted in an 
Applied Biosystems 7500 Fast Real-Time PCR System (Life Technologies) by using 
TaqMan® Fast Advanced Master Mix (Life Technologies). Each qPCR reaction plate also 
contained a standard curve ranging from 10
 
fg/µl to 1 ng/µl that was generated from MAP 
strain K10 genomic DNA, no template negative controls, and a positive control of MAP 
strain 19698 genomic DNA.  Amplification conditions were as follows: stage 1: 95˚C for 20 
sec, stage 2: 94˚C for 3 sec and 66˚C for 30 sec repeated for 40 cycles. All samples with a 
threshold cycle (Ct) less than or equal to 37 were considered positive. MAP growth was 
confirmed on the HEY medium slants by colony morphology and slow-growing 
characteristics. All colonies were compared with those present on the positive control sample 
slants. If any unusual colonies appeared, confirmatory protocols as stated above were 
performed.  
Classification of final culture results.  The final interpretation of positive or 
negative status of each milk sample after culture is shown in Table 1.  A sample was 
classified as positive if both the AF and PCR results confirmed the positive readout from the 
machine.  If the machine signaled positive but AF and PCR confirmatory tests were negative, 
the sample was considered either contaminated or false positive, depending upon the 
presence of non-MAP microorganisms in the sample. Samples were classified as negative if 
the machine signal was negative and both the AF and PCR confirmatory tests were negative.  
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A sample was considered a false negative if the AF and PCR results were both positive, 
following a negative machine signal. 
Statistical analysis.  Statistical analysis was performed by using the GLIMMIX 
procedure of the Statistical Analysis System (SAS Institute, Cary, North Carolina, USA). The 
model included the fixed effects of treatment (concentration of NaOH, time, culture medium, 
and antibiotics), sample (spiked milk), and treatment x sample interaction. When significant 
effects (P<0.05) because of treatment, sample, and treatment x sample interaction were 
detected, least square means separation were computed by Tukey-Kramer post-hoc test.   
 
Results 
 The effects of increasing concentrations of NaOH as a component of the NALC-
NaOH decontamination protocol on the recovery of viable MAP from experimentally 
inoculated raw milk are shown in Figure 1.  Data from milk samples inoculated with 10
8
 cfu 
of MAP/ml are not shown for simplicity of data presentation. Within the milk matrix, MAP 
demonstrated significant resistance to NaOH as a chemical decontaminant, as subjection of 
samples to NaOH concentrations ranging from 0.50% to 2.00% did not affect (P=0.34) the 
time to recovery, regardless of MAP concentration in the milk (Figure 1).  Although overall 
time to recovery was earlier for samples cultured in BACTEC 12B medium compared with 
samples cultured in para-JEM medium by an average of 3.2 days, the lack of NaOH lethality 
on MAP was noted for both media.   
To assess the effects of increasing times of exposure of MAP in milk to chemical 
decontamination with NALC-NaOH, only one concentration of NaOH (1%) was used 
(Figure 2).  Increasing times of exposure from 5 to 30 min did not affect the time to recovery 
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of MAP in either medium tested. Once again, BACTEC 12B medium had decreased recovery 
times compared with para-JEM by an average of 4.8 days (Figure 2). Although concentration 
of NaOH and exposure time did not affect the viability of MAP, there were notable effects on 
the level of contaminating microorganisms (Figure 3). The incidence of contamination in 
samples cultured in BACTEC 12B medium decreased sharply (P < 0.01) from 86.7 to 13.3% 
after treatment with NaOH concentrations of 0.50 and 1.00%, respectively. Sample 
contamination decreased to nondetectable levels when NaOH concentrations of 1.50 and 
2.00% were used.  A similar decrease in contamination level was observed when time of 
exposure to NaOH was increased (Figure 3). Contamination of raw milk samples decreased 
from 26.7% to 13.3% with exposure times of 5 and 15 min, respectively.  When samples 
were treated with 1.00% NaOH for 30 min, the presence of contaminating microorganisms 
was negligible.  Distinct thresholds in both NaOH concentration and exposure time were 
observed for samples incubated in BACTEC 12B, where NaOH was able to effectively 
suppress contamination. These thresholds consisted of treatment of samples with either 
NALC-1.50% NaOH for 15 min or treatment with NALC-1.00% NaOH for 30 min. The 
para-JEM medium demonstrated a greater ability to suppress contaminating microorganisms, 
with no significant amounts of contamination detected, regardless of concentration of NaOH 
or time of exposure (data not shown).  
 BACTEC 12B, para-JEM, and HEY media differed significantly in the capacity and 
efficiency of recovering MAP from decontaminated milk samples. It quickly became 
apparent that HEYM was inferior to the liquid media for recovery of MAP from milk, with 
limits of detection estimated to be 10
4
 cfu/ml. Because recovery rates were so poor for HEY 
medium they are not presented here. There were no significant differences observed in 
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sensitivity of detection between the liquid culture media across all spiking concentrations, 
though there was a tendency (P=0.17) for the BACTEC 12B medium to recover MAP faster 
than the para-JEM medium. Both media were able to recover all of the samples inoculated, 
including the lowest level of MAP inoculated into milk (10
2
 cfu/ml). When compared with 
previous studies where the effects of HPC concentration and time of exposure were explored, 
the NALC-NaOH protocol significantly decreased (P<0.01) time to recovery in both 
BACTEC12B and para-JEM media, as seen in Figure 4. This difference became more 
pronounced with lower inoculation levels. On average, decontamination with NALC-NaOH 
decreased the time to detection by 18.3 and 28.4 days in BACTEC 12B and para-JEM 
media, respectively, relative to decontamination with HPC. In addition, the accuracy of the 
systems of detection differed, as the para-JEM medium yielded 11.6% and 1.6% false 
positive or negative machine indications after being treated with HPC and NALC-NaOH 
respectively, whereas the BACTEC 12B medium had none regardless of treatment.  
 Overnight exposure of milk samples to the antibiotic cocktail, VAN, after 
decontamination with NALC-NaOH, had detrimental effects on the viability of MAP. A 
significant (P < 0.01) increase in time to recovery was observed after additional exposure to 
VAN for samples cultured in both BACTEC 12B and para-JEM media (Figure 5).  Further, 
an increase in undetectable samples was observed for samples cultured in the para-JEM 
medium, as two of the triplicate samples within the 10
2
 cfu/ml inoculation level were 
undetected after treatment with VAN, whereas all the replicates at this concentration were 
detected without exposure to VAN. The BACTEC 12B medium was able to detect all of the 
samples inoculated with 10
2
 cfu of MAP/ml, but there was a significant (P < 0.01) increase in 
time to recovery of 19 days after treatment with VAN. The effects of VAN treatment were 
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negligible because the rate of contamination in samples was low regardless, but 
contamination in the BACTEC 12B medium was decreased from 1/12 samples to 0/12 
samples after incubation with VAN. No contamination was seen in samples treated with 
either NALC-NaOH or NALC-NaOH plus VAN when cultured in para-JEM medium.  
 
Discussion 
The present study examined the effects of exposure of NALC-NaOH alone and in 
combination with VAN on the recovery of viable MAP from experimentally spiked raw milk. 
The application of the NALC-NaOH decontamination procedure to sputum samples prior to 
culture for M. tuberculosis was first reported in 1963 (14). The addition of the mucolytic 
agent NALC in conjunction with NaOH for the decontamination of sputum samples 
permitted a decrease in the concentration of NaOH from 4.0 to 1.0% without increasing the 
contamination rate. The decrease in NaOH concentration increased the number of sputum 
samples positive for M. tuberculosis from 53/129 to 81/129. It is speculated that the 
liquefaction of the sputum by NALC improved contact between the contaminating 
microorganisms and the NaOH, thereby permitting the use of lower concentrations of NaOH. 
This liquefaction also may have increased the recovery of MAP from milk samples in the 
present study by facilitating better recovery of the mycobacterium during centrifugation. 
Because milk and sputum have similar high protein contents, we hypothesized that NALC 
would have the same liquefaction effect on milk samples, permitting the use of NaOH 
concentrations lower than 4.0%. 
The present study demonstrated that decontamination of milk with NALC-NaOH 
effectively controlled the growth of contaminating microorganisms, while causing minimal 
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damage to viable MAP cells. We found that neither increasing concentrations of NaOH from 
0.5% to 2.0% in the NALC-NaOH decontamination protocol nor increasing length of 
exposure to the chemical treatment from 5 to 30 min significantly affected the viability of 
MAP. Our finding is contrary to other studies that have found both NaOH alone and in 
combination with NALC can be detrimental to the viability of mycobacteria (19, 20). When 
sputum samples were cultured for mycobacteria, an increase in NALC-NaOH concentration 
from 1.00 to 1.25% with a 15 min exposure time, caused the frequency of positive cultures to 
decrease from 21 to 11%, respectively (20). Likewise, another study on M. bovis suspended 
in tissue homogenate reported a decrease in survival rate from 89.0 to 4.1% when the 
concentration of NaOH is increased from 0.001 to 10.0% exposed for 30 min (19). When 
NaOH has been used in a singular fashion to decontaminate samples, it was shown to be 
lethal to mycobacteria, depending upon the concentration and the time of exposure.  
Different species of mycobacteria, however, have variable levels of tolerance to 
NaOH. A study compared effects of decontamination of sputum with 1.7% NaOH and 3.0% 
sulfuric acid on the recovery of Mycobacterium spp. (21). When the samples were 
decontaminated with NaOH, a higher number of samples were positive for M. intracellulare 
than when decontaminated with sulfuric acid. Conversely, a higher number of samples were 
positive for M. lentiflavum when decontaminated with sulfuric acid than with NaOH. This 
observation demonstrates that M. intracellulare has a higher tolerance for exposure to NaOH 
than does M. lentiflavum.  In our protocol, we chose to neutralize the NaOH by adding excess 
amounts of PBS, as it was a quick and simple method of neutralization. Another option 
would have been to use a pH indicator and acid to neutralize the solution. We chose not to 
use this option because it not only substantially increased the labor time, but the resulting 
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samples would become opaque, an effect that could interfere with the machine indicators 
during culture. 
Increased concentrations and length of exposure to NALC-NaOH were effective in 
controlling the presence of contaminating microorganisms in milk samples. We observed 
threshold values of NaOH concentration and length of exposure that allowed for very few 
contaminating microorganisms to survive. These threshold values were NALC-1.50% NaOH 
with an exposure time of 15 min or a lower concentration of NALC-1.00% NaOH with 
exposure times extended to 30 min. Either of these threshold combinations would likely be 
acceptable options as decontamination protocols. Because there was a larger decrease in 
incidence of contamination as the concentration of NaOH was increased when compared 
with increased exposure times, we selected the former as the optimal protocol. In addition, 
clinical microbiology handbooks suggest increasing NaOH concentrations over increasing 
length of exposure (22, 23).  
Hexadecylpyridinium chloride has been the most common chemical used for 
decontamination of milk for the isolation of MAP, even though it has been shown to be 
detrimental to the viability of MAP. In a previous study evaluating the effects of  HPC 
decontamination on MAP, the mean recovery of MAP in milk after exposure to 0.75% HPC 
for 5 hours was estimated to be 28.7% (12). When the time of exposure to HPC was 
increased to 24 hours, 45% more MAP cells were killed than at 5 hours exposure (10). In the 
present study, we found that treatment with NALC-NaOH always led to a faster time to 
recovery regardless of MAP concentration or the medium used for culture when compared 
with treatment with HPC.  The faster time to recovery after NALC-NaOH decontamination 
could be multi-factorial. First, MAP could be more resistant to NaOH than to HPC as the two 
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chemicals disrupt the cells via different mechanisms (24, 25). Interestingly, NaOH  in 
conjunction with oxalic acid is less detrimental to MAP during decontamination of fecal 
samples than HPC (26). The number of fecal samples from which MAP was isolated 
increased from 3/186 when decontaminated with 0.75% HPC followed by incubation with 
VAN to 15/186 when decontaminated with 4.0% NaOH followed by incubation with 5.0% 
oxalic acid. Secondly, there could be more effective neutralization and less carryover of the 
chemical into culture with NALC-NaOH treatment than with HPC treatment because the 
NaOH is neutralized by dilution, whereas no steps are taken to neutralize the HPC. Lastly, 
the reduction of disulfide bonds by NALC causes liquefaction of the milk sample that may 
allow for better partitioning of MAP into the cream and pellet fractions during centrifugation, 
leading to an increased rate of recovery.  
 We had previously encountered deficiencies in the use of HEY medium for the 
culture of MAP from raw milk after decontamination with HPC. Many of the same 
deficiencies were encountered with milk decontaminated with NALC-NaOH. These 
deficiencies include a high threshold of detection, around 10
4
 cfu of MAP/ml, and technical 
issues with inoculation of the medium and enumeration of the colonies.   
 The BACTEC 12B and para-JEM media performed considerably better than HEYM. 
The BACTEC 12B medium consistently detected growth of the samples faster than did the 
para-JEM medium, though the difference was not statistically significant. The BACTEC 12B 
medium had significantly higher contamination rates at low concentrations of NaOH and 
shorter exposure times than did the para-JEM medium. The contamination that was observed 
in samples cultured in the BACTEC 12B medium was primarily fungal. This result is 
contrary to previous studies in our laboratory evaluating the use of HPC chemical 
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decontamination in which contamination occurred in both media and was primarily found to 
be bacterial with Staphylococcus, Bacillus, and Pseudomonas species isolated. 
The varying performance of the media could be caused by differences in media 
formulation and growth detection. Major formulation differences include formulation of egg 
yolk supplements, varying antibiotics, and addition of other modifying agents to the media. 
The methods of detecting growth by each media are also quite different. The BACTEC 460 
machine detects evolved radioactive carbon dioxide after bacteria oxidize 
14
C-labeled 
palmitic acid within the headspace of the BACTEC 12B medium bottle. The ESP culture 
system II machine detects a decrease in headspace pressure of the para-JEM medium bottle. 
The detection methods employed in the para–JEM medium are less sensitive than the 
BACTEC 12B medium which could partially account for the increase in time to detection of 
growth in para-JEM medium. Interestingly, samples treated with HPC had a higher incidence 
of false signals than if they were treated with NALC-NaOH. Collectively, the BACTEC 12B 
medium and the BACTEC 460 machine achieved results that were superior to the para-JEM 
medium and the ESP culture system II in regards to both detection thresholds and time to 
detection. 
Antibiotic cocktails frequently are used in conjunction with chemical decontaminants 
to control growth of contaminating microorganisms during culture. The VAN antibiotic 
cocktail is frequently used even though studies have noted that VAN in these concentrations 
is detrimental to the viability of MAP, with the suggestion to decrease the concentration of 
vancomycin and nalidixic acid to 50 µg/ml (10, 27-29). In the present study, VAN exposure 
had detrimental effects on viability of MAP and contaminating microorganisms. The lethal 
effects of VAN observed may be compounded by prior exposure to NALC-NaOH. NALC-
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NaOH can damage the MAP bacterium and may cause it to be more vulnerable to the 
antibiotics to which it is normally resistant. Also, the lethal effects of VAN may be 
compounded in the para–JEM medium because it already contains vancomycin, unlike 
BACTEC 12B, which is known to have detrimental effects on the viability of MAP (30). The 
marked decrease in viability is not a reasonable accommodation for the decrease in 
contaminants, especially when the goal is to define a protocol able to detect low 
concentrations of MAP present in milk. Further studies should investigate whether different 
antibiotics would have similar effects on MAP or whether decreasing the concentration of 
each antibiotic in the cocktail would decrease the detrimental effects observed for VAN on 
MAP in this study. 
In conclusion, we recommend decontaminating raw milk with NALC-1.50% NaOH 
for 15 min at RT to maximize the recovery of MAP from raw milk while minimizing the 
amount of contaminating microorganisms. The BACTEC 12B medium has fastest time to 
detection and the easiest growth confirmation of the three media evaluated, though 
appropriate precautions must be taken to handle the radioactive medium. Although BACTEC 
12B medium is no longer commercially available, the para-JEM medium is a less convenient 
but viable alternative. The ability to accurately assess shedding of viable MAP into milk of 
naturally infected cattle is crucial to provide producers credible information about the risk of 
transmitting MAP to calves via consumption of milk from infected cows.  
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Table 3.1. Classification of the final status of each milk sample based upon machine 
indication, acid-fast stain, and IS900 PCR results. 
Machine Indicator Acid-Fast (AF) IS900 PCR Interpretation 
Positive Positive Positive Positive 
Positive 
Negative 
Non-AF organisms present 
Negative Contaminated 
Positive Negative Negative False Positive 
Negative Negative Negative No Growth 
Negative Positive Positive False Negative 
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Figure 3.1. Time to recovery of Mycobacterium avium subsp. paratuberculosis in raw milk 
spiked with 10
2
 – 106 cfu/ml after treatment with 0.50, 1.00, 1.50, and 2.00% sodium 
hydroxide for 15 min in BACTEC 12B and para-JEM media (N-acetyl-L-cysteine and 
sodium citrate concentrations were held constant at 0.5% and 1.45%, respectively). Missing 
data are the result of contamination in all three replicates of the sample. Data are expressed 
as means ± SEM, n=3:  A) 10
2
 cfu/ml; B) 10
4
 cfu/ml; C) 10
6
 cfu/ml. 
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Figure 3.2. Time to recovery of Mycobacterium avium subsp. paratuberculosis in raw milk 
spiked with 10
2
 – 106 cfu/ml after treatment with 1.00% sodium hydroxide for 5, 15, and 30 
min in BACTEC 12B and para-JEM media (N-acetyl-L-cysteine and sodium citrate 
concentrations were held constant at 0.5% and 1.45% respectively). Data are expressed as 
means ± SEM, n=3: A) 10
2
 cfu/ml; B) 10
4
 cfu/ml; C) 10
6
 cfu/ml. 
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Abstract 
 Mycobacterium avium subsp. paratuberculosis (MAP) is shed into the milk of cattle 
affected by Johne’s disease and, therefore, is a route of transmission for infection in young 
stock in dairy herds. The objective of this study was to validate a decontamination and 
culture protocol for the isolation of MAP from individual raw bovine milk samples. In the 
first portion of the study, milk samples (n=17) were collected from a herd infected with MAP 
and were decontaminated with 0.75% hexadecylpyridinium chloride for 5 hours or N-acetyl-
L-cysteine-1.5% sodium hydroxide  (NALC-1.5% NaOH) for 15 minutes prior to inoculation 
into BACTEC 12B, para-JEM, and Herrold’s egg yolk (HEY) media. In the second portion 
of the study, milk samples (n = 144) were collected from dairy cows at 7 dairy 
establishments across the US. Milk samples were decontaminated by exposure to NALC-
1.5% NaOH for 15 minutes prior to inoculation into BACTEC 12B, para-JEM, and 
Herrold’s egg yolk (HEY) media.  The first portion of the study demonstrated that treatment 
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with NALC-NaOH resulted in a lower percentage (6%) of contaminated samples than did 
treatment with HPC (47%), regardless of media. Recovery of viable MAP from milk samples 
in the second portion of the study was low, regardless of culture medium, with recovery from 
2 samples cultured in BACTEC 12B medium, recovery from 1 sample cultured in para-JEM 
medium, and no viable MAP recovered on HEY medium. However, 32 cows were fecal 
culture positive and 13 milk samples were found to be positive by direct PCR, suggesting 
that a number of cows were actively shedding MAP at the time of milk collection. 
Contamination rates were similar across media, with 39.6, 34.7, and 41.7% of samples 
contaminated after culture in BACTEC 12B, para-JEM, and HEY media, respectively. Herd-
to-herd variation had a major impact on sample contamination, with percentage of 
contaminated samples ranging from 4% to 83%. It was concluded that decontamination of 
milk with NALC-1.5% NaOH prior to culture in BACTEC 12B medium was the most 
efficacious method for the recovery of viable of MAP from milk, though the ability to 
suppress the growth of contaminating microorganisms varied greatly between herds.  
 
Short Communication 
Johne’s disease (JD) is a slow progressing, chronic granulomatous enteritis of the 
small intestine caused by Mycobacterium avium subsp. paratuberculosis (MAP) (1). The 
dairy industry continues to struggle to control this disease, with the US dairy herd-level 
prevalence estimated to be 91.1%, costing the US dairy industry more than $200-250 million 
annually (2, 3). As JD progresses, MAP can disseminate from intestinal tissues throughout 
the body and has been isolated from milk, supramammary lymph nodes, and lymph fluid 
from the udder (4-6). Milk and colostrum from infected cows may be consumed by 
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susceptible neonates and youngstock, thereby potentiating the spread of infection within the 
herd. With this in mind, producers in the dairy industry need to have accurate information on 
the quantity of MAP shed into milk and colostrum.  
 Exogenous contamination (outside of the udder) of raw milk occurs primarily from 
dirty udders and improperly cleaned and sanitized milking equipment (7). Milking facilities 
use different procedures to clean and sanitize milking equipment, leading to different levels 
of microbial contamination in raw milk post-milking. Some microorganisms commonly 
found in bulk tank milk include Bacillus spp., coliforms, Enterococcus spp., Lactococcus 
spp., Micrococus spp., non-coliforms, Pseudomaonas spp., Staphylococcus spp., 
Streptococcus spp., other Gram positive rods, and yeasts (8). For this reason, it is necessary 
to include a decontamination step in the protocol to culture MAP from raw milk. The first 
goal of this study was to identify which of two previously optimized decontamination 
protocols, treatment with hexadecylpyridinium chloride (HPC) or N-acetyl-L-cysteine-
sodium hydroxide (NALC-NaOH), resulted in the lowest levels of contaminated cultures. 
The second goal of this study was to evaluate the effectiveness of the NALC-NaOH 
decontamination protocol to decrease microbial contamination of raw milk obtained from 
dairies across the US. Further, the combined effects of the ability to recover viable MAP 
from raw milk samples while dampening growth of contaminating microorganisms were 
compared for 3 culture media: BACTEC 12B, para-JEM media, and Herrold’s egg yolk 
(HEY).  
This study was split into two portions. In the first portion, milk was collected into 
sterile containers from a JD-positive herd. The milk was decontaminated with two different 
decontamination protocols. A 20 mL aliquot of each milk sample was centrifuged at 5600 x g 
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for 30 min at 4˚C. The whey layer was discarded, and the cream and pellet layers were 
retained and subjected to decontamination with either NALC-NaOH or HPC. The NALC-
NaOH decontamination protocol consisted of resuspending the cream and pellet in sterile 
phosphate-buffered saline (PBS, Sigma-Aldrich) to a final volume of 5 mL. An equal volume 
of a solution containing 0.5% NALC-3.0% NaOH-1.45% sodium citrate was added (final 
concentration of 1.5% NaOH)  and allowed to incubate for 15 min at room temperature (RT, 
22˚C). Immediately after the incubation, 15 mL of PBS was added to dilute the NALC-
NaOH solution. Samples subjected to the HPC decontamination protocol were resuspended 
in 5 mL of 1.05% HPC (0.75% final concentration) and allowed to incubate at RT for 5 
hours. After chemical exposure, all samples were centrifuged at 5600 x g for 30 min at 4°C, 
the chemical layer was discarded, and the cream and pellet were resuspended in 1 mL of PBS 
for inoculation of the media.  
In the second portion of this study, 7 dairy herds across the US were selected on the 
basis of known JD status and willingness of the producer and assisting veterinarians to 
collect samples. Cows were selected preferentially for sampling if they had previously tested 
positive for JD by fecal culture. Feces and milk from each cow were collected into clean 
containers, and each container was placed into a separate plastic ziplock bag to avoid cross-
contamination during shipment.  Samples were immediately shipped on ice and then stored at 
-80˚C until processing.  
To assess the disease status of the cow, the fecal samples were cultured for MAP. The 
decontamination protocol was adapted from a previously published protocol where 2 g of 
feces were incubated overnight in 0.75% hexadecylpyridinium chloride (Sigma-Aldrich, St. 
Louis, MO) at 39˚C  followed by overnight incubation in an antibiotic cocktail consisting of 
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100 µg/mL vancomycin, 50 µg/mL amphotericin B, and 100 µg/mL nalidixic acid (9). The 
samples were inoculated into para–JEM medium as described below. Milk samples were 
subjected to the NALC-NaOH decontamination protocol and inoculated into the three media 
as detailed below. 
The BACTEC 12B medium (Becton Dickinson (BD), Franklin Lakes, NJ) was 
supplemented with 0.5 mL unmodified raw egg yolk (in-house), 0.2 mL PANTA Plus (BD), 
0.1 mL of 50 µg/mL mycobactin J, and 1.2 mL sterile deionized water. Each bottle was 
inoculated with 200 µL of decontaminated milk sample and placed in a 37˚C incubator until 
the growth index indicated by the BACTEC 460 machine (BD) reached 300 or the end of the 
84-day incubation period was reached. The para-JEM medium (Thermo Fisher Scientific; 
TREK Diagnostic Systems, Inc., Cleveland, OH) was supplemented according to the 
manufacturer’s instructions. Each bottle was inoculated with 500 µL of decontaminated milk 
sample and placed into the ESP Culture System II incubator (Thermo Fisher Scientific; 
TREK Diagnostic Systems, Inc.) until a positive bottle was indicated or for up to 65 days 
according to the manufacturer’s instructions. Three HEY medium slants (BD) containing 
mycobactin J, vancomycin, amphotericin B, and nalidixic acid were inoculated with 100 µL 
of decontaminated milk sample. The slants were allowed to incubate at 39˚C for 12 weeks. 
The colonies were counted at 4, 8, and 12 weeks post-inoculation.  
To confirm the identity of growth of the cultures, a Ziehl-Neelsen acid-fast stain was 
performed on all bottles subject to MAP growth confirmation. If the sample was positive for 
acid-fast bacteria, DNA was extracted from aliquots of the culture medium by using the 
MagMAX Total Nucleic Acid Isolation Kit (Life Technologies Corporation, Carlsbad, CA) 
on the MagMAX Express machine (Life Technologies) as directed by the manufacturer. The 
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extracted DNA was assayed for the presence of MAP by using real-time PCR with the MAP-
specific IS900 target conducted in an Applied Biosystems 7500 Fast Real-Time PCR System 
(Life Technologies) with TaqMan Fast Advanced Master Mix (Life Technologies) by using a 
previously published primer and probe sequences and thermal profile (10). MAP growth was 
confirmed on the HEY medium slants by colony morphology and slow-growing 
characteristics. All colonies were compared with those present on the positive control sample 
slants. If any unusual colonies appeared, confirmatory protocols as stated above were 
performed. Acid-fast positive, PCR negative organisms were identified by partial 16S rRNA 
gene and rpoB gene sequencing (11, 12). A sample was classified as positive or negative 
only if both the acid-fast and PCR results confirmed the readout from the machine. If the 
machine signal was conflicting with the confirmation results, the samples were classified as 
either false positive or negative.  
The presence of MAP in the sample also was ascertained by direct PCR. The milk 
sample (10 mL) was centrifuged at 5600 x g for 30 min at 4˚C. The whey layer was removed, 
and the remaining cream and pellet were resuspended in 800 µL of PBS and transferred to a 
sterile 1.5 mL tube containing 200 µL of 10 mg/mL proteinase K (Qiagen, Valencia, CA). 
The samples were incubated at 56˚C for 1 hour and then centrifuged at 15,000 x g for 15 min. 
The liquid fraction was removed, and the cream and pellet were resuspended in 200 µL of 
PBS. An aliquot (175 µL) was transferred to a MagMAX Total Nucleic Acid Isolation Kit 
bead beat tube and the manufacturer’s protocol was followed by using the MagMAX Express 
machine. Real-time PCR targeting the IS900 gene was performed as before except for the use 
of TaqMan
®
 Environmental master mix 2.0 (Life Technologies). All samples with a 
threshold cycle (Ct) less than or equal to 42 were considered positive.   
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Statistical analysis was performed by using the GLM procedure of the Statistical 
Analysis System (SAS Institute, Cary, North Carolina, USA). The model included the fixed 
effects of state, media, and state x media interaction.  
 Treatment of the milk samples with NALC-NaOH resulted in lower contamination 
rates across all the media than did treatment with HPC (Table 4.1). Within treatment with 
HPC, BACTEC 12B medium performed the best with 3/17 samples contaminated and para-
JEM HEY media performed worse with 11/17 and 10/17 samples contaminated, respectively. 
When the samples were treated with NALC-NaOH, para-JEM medium had no contamination 
and BACTEC 12B and HEY media performed equally with 1/17 samples contaminated. 
Therefore, the NALC-NaOH decontamination protocol was selected to be applied to the 
second portion of this study.  
The data from the second portion of this study are summarized in Table 4.2. Out of 
144 cows sampled, 32 were found to be shedding MAP into their feces. Because cows can be 
asymptomatically infected with MAP without shedding into the feces, we cannot 
conclusively say that the cows that were fecal-culture negative did not have JD (1). It is 
noteworthy that the sample set is not an accurate representation of animal level prevalence 
within a herd because animals that were either known or suspected to have JD were targeted 
for sampling.  
Only two milk samples were positive for MAP via culture. This finding was not 
surprising because it is speculated that the amount of MAP shed into milk is correlated with 
how advanced the disease is (4). The cow will manifest clinical symptoms in the late stages 
of JD, so it is likely the cow will quickly be culled. Therefore, it is probable that most, if not 
all, of the milk samples were collected from cows not manifesting any symptoms, leading to 
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a low likelihood of MAP being shed into the milk. If MAP is shed into the milk at pre-
clinical stages of the disease, it is shed at very low concentrations, 2-8 cfu of MAP/50 mL, 
and this may have been beyond the detection limits of our culture methods (4). MAP was 
isolated from the feces of only one of the two cows that had positive milk samples. This 
inconsistency can be explained as MAP is shed into the feces intermittently throughout the 
progression of JD (1). At the time of sampling, this cow may not have been actively shedding 
MAP into the feces but could still have been highly infected with MAP. Because little 
research has been conducted as to when and how MAP is shed into milk, it is difficult to 
speculate whether a cow sheds MAP into feces and milk at the same time or whether they are 
independent of one another (13).  
Of the two positive samples, only one was positive in both BACTEC 12B and para-
JEM media. No samples were positive on HEY medium, as culture detection thresholds (10
4
 
cfu/mL) are much higher for MAP on this medium. The sample that was positive for both 
liquid media was detected at 49 days in BACTEC 12B medium and 57 days in para-JEM 
medium. The sample that was positive for MAP growth only in BACTEC 12B was detected 
in the last week of incubation (77-84 days). Both of these samples are consistent with 
previous studies in our laboratory where growth detection occurred earlier in BACTEC 12B 
medium than in para-JEM medium (Bradner, unpublished data). BACTEC 12B medium was 
incubated for 84 days whereas para-JEM was incubated for 65 days per the manufacturer’s 
instructions. This shorter incubation time may have contributed to the failure of  para-JEM 
medium to detect this sample. The BACTEC 12B medium was more adept at isolating other 
species of mycobacteria from milk samples than was para-JEM and HEY media. Some of 
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these non-MAP mycobacteria were identified as M. fortuitum, M. moriokaense, and M. 
smegmatis, all soil or water-dwelling bacteria (14).  
 The frequency of MAP detection in the milk samples was much higher via direct PCR 
(13 of 144 samples) than by culture (2 of 144 samples). This higher incidence can be 
explained by the ability of PCR to detect both viable and non-viable bacteria. Therefore, if 
MAP is shed from the mammary gland via the milk in a non-viable form, PCR will still 
detect its presence. Even though nonviable MAP is noninfectious, it is still important that it is 
shed into the milk. Exposure to MAP antigens, like those in heat-killed vaccines, can 
interfere with serological diagnostic tests for JD because they induce host immune responses 
to MAP that would not normally be present in healthy animals (15). The higher detection by 
PCR compared with culture may also be a factor of the decontamination procedure applied to 
the milk samples before culturing. Although the NALC-NaOH protocol was designed to 
minimize the detrimental effects on MAP, it still may decrease the viability of MAP present 
in the sample, resulting in false negative samples. 
 Overall, the three media performed equally in ability to suppress contaminating 
microorganisms. BACTEC 12B, para-JEM, and HEY media had 39.6, 34.7, and 41.7% of 
the samples contaminated, respectively. No statistical significance (P<0.05) was found 
though there was a trend (P=0.09) for herd-to-herd variation to affect contamination 
Examples of contamination on HEY medium are shown in Figure 4.1. It is important to 
suppress the growth of all contaminating organisms as their quick growth rate relative to 
MAP rapidly overgrows the culture medium, rendering it ineffective for the growth and 
detection of MAP. As can be seen in Table 4.2, the three media generally were able to 
suppress the growth of contaminating microorganisms equally within each herd sampled. It 
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should be noted that between herds there was a large variation in contamination levels 
ranging from 4% of milk samples from the Iowa B herd cultured in BACTEC 12B medium 
to 83% of milk samples from the South Carolina herd cultured in para-JEM medium. This 
considerable difference in contamination rates is likely caused by different methods of 
collecting samples and levels of cleanliness in milking equipment. Milk samples were 
collected by different people, leading to differences in teat cleaning and milk handling 
practices. In addition, milk residues left by poor cleaning of the milking equipment supports 
the growth of a variety of microorganisms (8). Research has found that sufficient water 
temperature (≥35˚C) during cleaning milking equipment was the most influential factor in 
lessening the bacterial load present in bulk-tank milk (16). The milking parlor designated as 
Iowa B closely monitors the water temperature of the wash cycles of the milking equipment 
on a routine basis and the attention to hygiene practices was demonstrated by the lowest 
levels of sample contamination of all the locations sampled. It is unknown whether other 
locations check the water temperature in their milking parlors and how frequently this 
checking is done. In addition, the concentration of microorganisms in milk can be influenced 
by the general health of the cows which can be affected by management procedures and feed 
quality.  
 In conclusion, the present study validated the efficacy of the NALC-NaOH 
decontamination and culture for the recovery of viable MAP from raw milk samples. The 
contamination rates were similar across media. The liquid media performed better for culture 
of MAP from milk, but the number of positive samples was very low for this sample set. 
Based on the failure of the para-JEM medium to detect one of the two positive samples and 
previous work in our laboratory, it may be efficacious to extend incubation time of milk 
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culture to 84 days. In addition, this study provided valuable information that proper sampling 
technique is necessary to ensure that milk samples have the lowest contaminating bacteria 
concentration possible prior to culture for MAP. This study demonstrates the need for 
producers to take caution when making decision on calf rearing practices. 
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Table 4.1. Number of contaminated milk samples after treatment with either 
hexadecylpyridinium chloride (HPC) or N-acetyl-L-cysteine-sodium hydroxide (NALC-
NaOH) and cultured in BACTEC 12B, para-JEM, or Herrold’s egg yolk medium (HEY). 1 
 
 Culture Media 
Chemical BACTEC 12B para-JEM HEY
2 
0.75% HPC 3 11 10 
NALC-1.5% NaOH 1 0 1 
1
Number of milk samples = 17 
2 
At least one of the three slants was contaminated 
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Figure 4.1. Examples of contaminated Herrold’s egg yolk medium slants with cultured raw 
milk. Slants A through E demonstrate various contaminants. Slant A was identified as 
Mycobacterium  hiberniae, slant B as an Enterobacter species and  slants C through E as 
Pseudomonas aeruginosa. Slant F was a positive control demonstrating Mycobacterium 
avium subsp. paratuberculosis (MAP) growth from a spiked milk sample. 
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Abstract 
 Mycobacterium avium subsp. paratuberculosis (MAP) is the causative agent of 
Johne’s disease (JD). One mode of transmission of MAP is through ingestion of 
contaminated milk and colostrum by susceptible calves. The objective of this study was to 
determine if the amount of MAP shed into the milk and colostrum of infected cows was 
impacted by severity of infection, as well as the number of days in milk (DIM). Milk was 
collected over the 305-d lactation period from 24 asymptomatic cows in the subclinical stage 
of disease, 20 symptomatic cows demonstrating clinical signs, and 6 noninfected control 
cows. Milk was assayed for MAP by culture with BACTEC 12B and Herrold’s egg yolk 
(HEY) media and by direct PCR for IS900 target gene. MAP was detected in 1.1, 2.7, and 
7.6% of milk samples collected from cows with subclinical JD and 9.5, 11.2, and 38.8% of 
milk samples collected from cows with clinical JD by culture in HEY medium, BACTEC 
12B medium, and direct PCR, respectively.  None of the milk samples collected from control 
cows were positive for MAP by any detection method. Viable MAP was primarily isolated 
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from milk and colostrum of subclinically and clinically infected cows collected in early 
lactation (DIM 0-60); with decreased incidence in mid (DIM 60-240) and late (DIM 240-
305) lactation. This study demonstrates that shedding of MAP into milk is impacted by 
infection status of the cow as well as DIM, providing useful information to producers to help 
break the cycle of infection within a herd.   
 
Introduction 
 Johne’s disease (JD) causes significant economic losses to the dairy industry, 
primarily because of reduced milk production and premature culling (1). Johne’s disease is 
caused by Mycobacterium avium subsp. paratuberculosis (MAP), taking many years for 
clinical symptoms to develop. Though primarily transmitted through ingestion of 
contaminated feces, MAP also can be transmitted through milk and colostrum, as well as in 
utero (2). As JD progresses, MAP can disseminate throughout the body and has been isolated 
from milk, supramammary lymph nodes, and lymph fluid from the udder (3-5).  
Milk and colostrum containing MAP can be consumed by neonates and youngstock 
that are most susceptible to MAP infection (6). Calves that are fed maternal colostrum are 
more likely to become infected with MAP than those that are fed colostrum replacer or 
pasteurized colostrum, indicating raw colostrum and milk may be the initial point of 
exposure for neonates (7, 8). Furthermore, if producers feed pooled milk or colostrum, they 
are increasing the likelihood of transmitting MAP to an even larger number of calves. 
Unfortunately, milk and colostrum replacer are an expensive alternative to feeding pooled 
milk and colostrum. 
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Little is known about the factors that influence the amount of MAP shed into milk. 
The excretion of MAP may be influenced by the stage of infection, with the highest shedding 
occurring in the clinical stages of JD and very little or even undetectable amounts of MAP 
shed in early stages (3). Days in milk (DIM) also may be correlated with the amount of MAP 
shed into milk and colostrum, because the volume and composition varies greatly throughout 
the 305-day lactation. The objectives of this study were to determine if a correlation exists 
between stage in JD, DIM, and the amount of MAP shed into milk and colostrum of naturally 
infected dairy cows.  
 
Materials and Methods 
Milk collection. Milk was collected for 50 complete 305-day lactation cycles over a 
period of 7 years from 42 cows well characterized for JD. Lactation cycles were stratified 
across infection status of cows as follows: clinical (n=20); subclinical (n=24); noninfected 
(n=6). Due to the long-term collection period, we were able to obtain samples from 2 
complete lactation periods from 8 of the 42 cows.  Milk was collected into sterile containers 
after thorough cleaning of the teats on days 1, 3, 7, 14, 21, 28, 90, 180, and 305 after calving. 
Milk was immediately frozen and stored at -80˚C until processing. Animals used in this study 
were housed at the National Animal Disease Center (NADC, Ames, IA). All procedures 
performed on the dairy cows were approved by the Institutional Animal Care and Use
 
Committee (NADC). 
Positive and negative control milk preparation. Milk was obtained from a 
noninfected healthy cow at the NADC. Milk from the cow was hand stripped into sterile 
collection containers after thorough disinfection of the udder and teats with iodine teat dip 
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and 70% ethanol. Large volumes of milk were collected at one time and stored at -80˚C until 
use. This milk was used for the negative control and also artificially spiked to a final 
concentration of 10
6
 cfu/mL with MAP strain 167 (obtained from a field isolate at the 
NADC) for the positive control.  
Decontamination of milk with NALC-NaOH. Each sample of milk was thawed 
overnight at 4˚C. The samples were lightly shaken to ensure a homogeneous sample. A 20 
mL aliquot of the milk was transferred to a sterile container centrifuged at 5600 x g for 30 
min at 4˚C. The whey layer was discarded, and the cream and pellet layers were retained. 
The cream and pellet layers were resuspended in phosphate buffered saline (PBS, Sigma-
Aldrich, St. Louis, MO) to bring the final volume to 5 mL. The samples were 
decontaminated with 5 mL of a solution containing sterile 1.45% sodium citrate, 3.0% 
sodium hydroxide, and 0.5% N-acetyl-L-cysteine (NALC-3.0% NaOH, Sigma-Aldrich).   
The NALC component of the solution was added immediately prior to use. The samples were 
inverted to mix, and incubated for 15 min at 22°C. Immediately after the incubation, 15 mL 
of PBS were added to dilute the NaOH. Samples were centrifuged at 5600 x g for 30 min at 
4°C, the aqueous layer was discarded, and the cream and pellet were resuspended in 1 mL of 
PBS for inoculation of the media.  
Media for recovery of MAP. Two media, BACTEC 12B and Herrold’s egg yolk 
medium (HEY), were used to culture MAP from milk.  The BACTEC 12B medium (Becton 
Dickinson (BD), Franklin Lakes, NJ) was supplemented with 0.5 mL unmodified raw egg 
yolk (in-house), 0.2 mL PANTA Plus (BD), 0.1 mL of 50 µg/mL mycobactin J, and 1.2 mL 
sterile deionized water. Each bottle was inoculated with 200 µL of decontaminated milk and 
placed in a 37˚C incubator. The growth index (GI) of the microorganisms in the bottles was 
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measured by the BACTEC 460 Machine (BD) twice per week for the first 2 weeks and then 
once per week for the following 10 weeks. The bottles were considered positive when the GI 
reached 300. Then, they were removed from incubation for MAP confirmation. At the end of 
the 12-week incubation period, all bottles were subject to MAP confirmation procedures.   
MAP recovery from milk also was evaluated on HEY medium (BD) and compared 
with BACTEC 12B liquid medium. Each slant of HEY medium containing mycobactin J, 
amphotericin B, nalidixic acid, and vancomycin (ANV) was inoculated with 100 µL of 
decontaminated milk sample in replicates of 3 agar slants per sample. The slants were 
allowed to incubate at 39˚C for 12 weeks and colonies were counted at 4, 8, and 12 weeks 
post-inoculation.  
MAP confirmation. A Ziehl-Neelsen acid-fast stain was performed on any sample 
with a positive GI in BACTEC 12 medium.  One drop of Acid Fast Mycohold Cell Adhesive 
(Wescore, Inc., South Logan, UT) was placed onto a microscope slide. About 100 µL of 
sample was added to slide and mixed thoroughly with the Mycohold. The slides were 
allowed to air dry and fixed in 100% methanol for 15 min at 22˚C. The slides then were 
stained with a standard Ziehl-Neelsen acid-fast stain followed by methylene blue counter 
stain.  
If the sample was positive for acid-fast bacteria, 500 µL of sample were removed 
from the bottle and added to 100 µL of proteinase K (10 mg/mL; Qiagen, Germantown, 
MD). The tubes were incubated at 56˚C overnight in an orbital water bath and then 
centrifuged at 15,000 x g for 15 min to separate the fractions of the sample. The supernatant 
was removed, and the pellet was resuspended in 175 µL of PBS. DNA was extracted from 
the pellet by using the MagMAX Total Nucleic Acid Isolation Kit (Life Technologies 
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Corporation, Carlsbad, CA) on the MagMAX Express machine (Life Technologies) as 
directed by the manufacturer.  
 The extracted DNA was assayed for the presence of MAP by using real-time PCR 
with the MAP-specific IS900 target. Primer and probe sequences for IS900 were as follows: 
200 nM forward primer 5’-CCGCTAATTGAGAGATGCGATTGG-3’, 200 nM reverse 
primer 5’-AATCAACTCCAGCAGCGCGGCCTCG-3’, and 100 nM probe 5’-
TCCACGCCCGCCCAGACAGG-3’ with a 5’ fluorescent FAM label and a 3’ TAMRA 
quencher (Integrated DNA Technologies, Coralville, IA). The real-time PCR was conducted 
in an Applied Biosystems 7500 Fast Real-Time PCR System (Life Technologies) by using 
TaqMan Fast Advanced Master Mix (Life Technologies). Each PCR reaction plate also 
contained a standard curve that was generated using MAP strain K-10 genomic DNA (10 
fg/µL to 1 ng/µL), no-template negative controls, and a positive control consisting of MAP 
strain 19698 genomic DNA. Amplification conditions were as follows: stage 1: 95˚C for 20 
sec, stage 2: 94˚C for 3 sec and 66˚C for 30 sec, repeated for 40 cycles. All samples with a 
threshold cycle (Ct) less than or equal to 37 were considered positive.  
 MAP growth was also confirmed on the HEY medium slants by PCR as stated above 
by placing suspect colonies into the beadbeat tube from the MagMax Total Nucleic Acid 
Identification Kit and following the manufacturer’s instructions . A sample was classified as 
positive or negative only if both the acid-fast stain and PCR results confirmed the GI or the 
presence of colonies. A sample was considered contaminated if there were acid-fast 
organisms present in the smear but the sample was negative for the IS900 gene. 
Direct PCR detection. The milk sample (10 mL) was transferred to a sterile tube and 
centrifuged at 5600 x g for 30 min at 4˚C. The whey layer was removed, and the remaining 
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cream and pellet were resuspended in 800 µL of PBS. As much of the solution as possible 
was transferred to a sterile 1.5 mL tube containing 200 µL of 10 mg/mL proteinase K. The 
samples were incubated at 56˚C for 1 hour and then centrifuged at 15,000 x g for 15 min. The 
liquid fraction was removed, and the cream and pellet were resuspended in 200 µL of PBS. A 
volume of 175 µL of this solution was transferred to a MagMAX Total Nucleic Acid 
Isolation Kit bead beat tube (Life Technologies), and the DNA was extracted on the 
MagMAX Express machine (Life Technologies) per the manufacturer’s instructions.  
 PCR targeting the IS900 gene was performed as before except using the TaqMan 
Environmental Master Mix 2.0 (Life Technologies). Amplification conditions were as 
follows: stage 1: 95˚C for 10 min, stage 2: 94˚C for 25 sec and 66˚C for 1 min, repeated for 
45 cycles. All samples with a threshold cycle (Ct) less than or equal to 42 were considered 
positive. 
 
Results 
 Results of culture and PCR on milk and colostrum samples collected from cows 
during the lactation cycle are presented in Table 5.1. MAP was detected most frequently in 
samples that were obtained from cows in the clinical stage of disease compared to cows that 
were subclinically infected, regardless of detection method.  Direct PCR was more sensitive 
than either BACTEC 12B or HEY culture medium for detection of the presence of MAP in 
either colostrum or milk samples.  Samples collected from clinical cows during the lactation 
cycle were 38.8% positive by PCR compared to 11.2% and 9.5% positive by culture on 
BACTEC 12B and HEY mediums, respectively. Although 185 samples were processed by 
culture and PCR from subclinically infected cows, MAP was detected with less frequency 
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regardless of detection method (Table 5.1). The highest level of MAP recovery was achieved 
by direct PCR with only 7.6% of samples positive. None of the samples from the control 
cows were positive as determined by any of the detection methods. Over the course of the 
305-day lactation cycle, 14 of the 20 clinical cows and 11 of the 24 subclinical cows were 
positive for MAP using PCR as the detection method.  The incidence of detection was 
reduced to 7 clinical cows and 3 subclinical cows when using either method of culture to 
detect MAP in the milk samples.   
 Of the 20 clinical cows, 11 died from JD within one year of calving (Table 5.2). 
Samples collected from these cows accounted for 12 of the 13 milk samples that were culture 
positive in BACTEC 12 B medium, and all of the milk samples that were culture positive on 
HEY medium. In addition, 33 of the 45 milk samples that were positive for MAP via direct 
PCR were collected from this group of clinical cows. 
Viable MAP was shed primarily into milk and colostrum in early lactation (DIM 0-
60) and less frequently shed in mid (DIM 60-240) and late (DIM 240-305) lactation (Table 
5.1). All of the MAP-positive milk and colostrum samples from cows with clinical JD were 
collected in early lactation. Likewise, 4 of 5 positive milk and colostrum samples from 
subclinical cows were collected in early lactation and only 1 positive sample was collected in 
mid-lactation. This trend persisted when the presence of MAP was detected by direct PCR. 
Of the direct PCR positive samples collected from clinical cows, 41 of 45 were detected in 
early lactation and 4 of 45 were detected in mid lactation. Similarly, 8 of the 14 positive 
samples were collected in early lactation, 3 in mid lactation, and 3 in late lactation.  
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Discussion 
 This study investigated the shedding of MAP into milk and colostrum over 305-day 
lactation cycles from naturally infected dairy cows. The results indicated a strong correlation 
between the amount of MAP shed into milk and colostrum and stage in JD progression. With 
more advanced MAP infection, the likelihood increased for MAP detection by PCR or 
isolation of viable MAP by culture. MAP was detected by direct PCR in 38.8% and 7.6% of 
samples collected from cows in the clinical and subclinical stages of JD, respectively. 
Likewise, MAP was detected by culture in the BACTEC 12B medium in 11.2% and 2.7% of 
samples collected from cows in the clinical and subclinical stages of JD, respectively.  
One possible model for the dissemination of MAP as JD progresses is the migration 
of intestinal macrophages containing MAP to the mesenteric lymph nodes, leading to the 
possibility of hematogenous or lymphatic spread of MAP. This spread of MAP allows it to 
infiltrate milk, blood, semen, and other extra-intestinal tissues such as the mammary lymph 
nodes (3, 5, 9, 10). One study found that the proportion of culture-positive milk samples and 
supramammary lymph nodes was higher in cows that were heavily shedding MAP into their 
feces than cows that were classified as intermediate or light shedders (3). To further support 
this finding, a recent study examined lymph fluid collected from the udder of clinical, 
subclinical, and negative cows from herds with a high prevalence of JD (4) .  The lymph 
fluid was positive for the MAP-specific gene target IS900 by PCR with increasing 
occurrence in samples collected from clinical cows (66.7%), as compared to cows that were 
subclinically infected (42.8%) and negative (38.7%).  
The number of milk samples determined to be positive for MAP was much higher by 
direct PCR than the number detected by culture, regardless of whether they were collected 
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from cows with clinical or subclinical JD. This discrepancy can be explained by the fact that 
PCR can detect both live and dead bacteria, thereby increasing the likelihood of detection 
since intracellular MAP may have been killed by macrophages within the mammary gland.  
Secondly, direct PCR has lower detection threshold than either culture method used in the 
present study. Previous experiments conducted in our laboratory comparing the efficacy of 
PCR and culture demonstrated a sensitivity of detection of less than 10
2
 cfu/mL for BACTEC 
12B medium, 10
4
 cfu/mL for HEY medium, and less than 10 cfu/mL for direct PCR. Culture 
is beneficial because it provides information on the presence of live, infectious bacteria 
present in milk samples but it also has a higher detection threshold due to methods used to 
process the samples.  Milk samples must be decontaminated prior to culture due to the 
presence of confounding microorganisms including other bacteria, molds, and fungi.  
However, decontamination procedures applied to the milk are potentially lethal to MAP (11, 
12). In addition, the decontamination and processing of milk samples prior to culture may 
result in loss of MAP due to centrifugation, partitioning of the sample, and dilution factors. 
PCR provides more information because a positive result may be indicative of the presence 
of either whole or fragmented MAP cells.  Both of these are important as even fragmented 
nonviable MAP can elicit immune responses when ingested, leading to inflammatory 
reactions within the host. Detection by PCR is also advantageous as it allows for same day 
acquisition of results compared with 12 weeks to obtain results from culture.  
Viable MAP was isolated primarily from milk and colostrum in early lactation. This 
finding can be explained in part by differences in milk and colostrum composition. Milk fat 
can be as high as 6% at the beginning of lactation and then drops to around 3.7% at around 
10 days post-calving (13). MAP preferentially partitions into the cream fraction of milk, so it 
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is possible that MAP will be more easily shed into milk with a higher fat content (14). 
Additionally, during the dry period, the percentage of mononuclear macrophages increased 
from 8 to 29% in the mammary gland from day 1 of the dry period to between -2 and 0 days 
before parturition, respectively (15). If this influx of macrophages into the mammary gland 
contained macrophages infected with MAP, it could result in the introduction of a higher 
concentration of MAP into the colostrum. Thereby, the physiologic events that normally 
occur at parturition could be responsible for the increased detection of MAP in samples 
obtained during early lactation.   
When examining the results for MAP detection on an individual cow basis, some 
interesting findings became apparent for cows that were classified as clinical.  Of the 20 
lactations that were sampled from clinical cows, 11 of these cows died within one year of 
calving. These lactations accounted for 12 of the 13 culture positive samples and 33/45 direct 
PCR positive samples.  These findings are consistent with what would be expected as 
dissemination of MAP throughout the body and shedding of MAP into the feces increases as 
JD progresses (2, 16). Therefore, it appears the frequency and amount of MAP shed into milk 
and colostrum increases continuously until the animal succumbs to JD.  
Interestingly, MAP was isolated from the colostrum and milk of a first lactation 
subclinical cow on days 1, 3, and 7 after calving. This result was contrary to results from the 
other milk samples collected from subclinical cows. It is difficult to speculate why this young 
cow in particular was shedding MAP into the milk so consistently. MAP shedding into the 
milk was sporadically detected for other subclinical cows, as would be expected in early 
stages of MAP infection since MAP shed into the feces is intermittent (17).  
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Unfortunately, very few samples were obtained from mid and late lactation from 
cows in the clinical stage of JD, primarily because the animals succumbed to JD in the early 
days of lactation. It would have been interesting to see if MAP was steadily shed into the 
milk throughout the complete lactation cycle, whether shedding was intermittent like fecal 
shedding, or whether MAP shedding continued to increase as JD progressed.  However, in 
order to accurately assess to obtain a better understanding of when and how MAP is shed into 
milk and colostrum it may be necessary to develop more sensitive detection methods.  
In summary, this study definitively demonstrates that MAP is shed into milk and 
colostrum, preferentially by cows in advanced stages of JD and in early lactation. This 
demonstration proves dam to calf transmission of MAP by milk consumption is a viable 
route of transmission. More importantly, research has found that exposure of MAP to high-
osmolarity environments, like those found in bovine mammary epithelial cells and milk, 
causes a change in the gene expression in MAP that is associated with an invasive phenotype 
(18). A meta-analysis of studies found that calves less than 6 months of age had a 74% 
chance of becoming infected upon exposure to MAP, with likelihoods decreasing to 50% 
between 6 to 12 months of age and 19.3% in animals older than 12 months (6). Therefore, if 
a newborn calf is allowed to suckle even once, it is experiencing the highest likelihood of 
infection by MAP. Additionally, if producers feed pooled colostrum, many calves could be at 
risk of infection by MAP. Veterinarians now have critical information to educate dairy 
producers on the risk of MAP transmission through milk and colostrum and the need to 
change calf rearing practices to accommodate these findings. 
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Table 5.1. Isolation of Mycobacterium avium subsp. paratuberculosis from milk and 
colostrum collected from clinical, subclinical, and control cows cultured with BACTEC 12B 
and Herrold’s egg yolk (HEY) media and detected by direct PCR targeting the IS900 gene. 
Data are organized in to early (days 0-60), mid (days 60-240), and late (days 240-305) 
lactation. 
Disease 
Status 
DIM
1 No. of 
Samples
 Direct PCR 
BACTEC 
12B 
HEY
 
Clinical 0-60 104 41 13 11 
 
60-240 10 4 0 0 
 
240-305 2 0 0 0 
 
Total 116 45 13 11 
Subclinical 0-60 138 8 4 1 
 
60-240 35 3 1 1 
 
240-305 12 3 0 0 
 
Total 185 14 5 2 
Control 0-60 32 0 0 0 
 
60-240 8 0 0 0 
 
240-305 3 0 0 0 
 
Total 43 0 0 0 
1
Days in milk   
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Table 5.2. Isolation of Mycobacterium avium subsp. paratuberculosis from milk and 
colostrum collected from clinical cows that died from Johne’s disease within a year of 
calving cultured on BACTEC 12B and Herrold’s egg yolk (HEY) media and detected by 
direct PCR targeting the IS900 gene. 
Cow # Age
1 Calving 
Date 
Date 
Euthanized
2 DIM
3 Direct 
PCR 
BACTEC 
12B 
HEY 
 
1445 6 11/7/2011 11/22/2012 1 +  + + 
        3 + + + 
        7 + + ND
4 
        14 +  + + 
2324 5 4/12/2010 4/27/2010 1 ND ND ND 
        3 ND ND ND 
        6 ND ND ND 
        14 ND ND ND 
6551 4 11/7/2007 8/17/2008 1 + + + 
        2 +  ND ND 
        15 + ND + 
        20 +  ND ND 
312 unk
5 
5/8/2006 6/6/2006 1 +  cont.
6 
cont. 
        3 +  ND ND 
        6 +  cont. cont. 
        21 +  cont. cont. 
1433 unk 5/10/2006 7/1/2006 1 +  ND ND 
        3 +  + + 
        7 +  + + 
        20 +  cont. cont. 
1657 unk 7/10/2006 7/20/2007 1 +  ND cont. 
        2 +  + ND 
        7 +  ND ND 
        14 + cont. cont. 
        21 +  ND cont. 
        28 ND ND ND 
3949 5 4/15/2006 6/9/2006 2 ND ND ND 
        3 ND + + 
        5 ND ND cont. 
        13 +  ND ND 
        21 +  ND ND 
        28 +  cont. cont. 
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Table 5.2. (continued) 
Cow # Age 
Calving 
Date 
Date 
Euthanized 
DIM 
Direct 
PCR 
BACTEC 
12B 
Culture 
HEY 
Culture 
6391 unk 5/7/2006 6/22/2006 1 +  + + 
        3 +  + + 
        7 +  ND + 
        21 +  ND ND 
6278 unk 5/16/2006 2/11/2007 1 +  ND cont. 
        3 +  + ND 
        14 +  ND ND 
        21 +  ND ND 
        28 ND ND ND 
2075 6 4/20/2005 9/4/2005 1 ND ND ND 
        3 ND ND ND 
        8 ND ND ND 
        15 +  ND ND 
        22 ND ND cont. 
        29 ND ND cont. 
1
Age of cow at start of lactation 
2
Cows were either euthanized or died naturally 
3
Days in milk 
4
Not detected 
5
Unknown 
6
Slants completely overwhelmed with contamination
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CHAPTER 6. GENERAL CONCLUSIONS 
General Discussion 
Mycobacterim avium subsp. paratuberculosis and other microorganisms are found in 
milk. The goal of the first part of this research was to investigate various decontamination 
parameters to optimize the recovery of viable MAP, as well as effectively decreasing the 
amount of contaminating microorganisms also present in milk.  
First, the efficacy of decontamination of milk with hexadecylpyridinium chloride 
(HPC) was investigated. High concentrations of HPC and long lengths of exposure were 
detrimental to the viability of MAP, though they did not effectively decrease the viability of 
contaminating microorganisms. Incubating milk and HPC at 39˚C versus room temperature 
increased the concentration of contaminating microorganisms but did not affect the viability 
of MAP. Liquid media, BACTEC 12B and para-JEM, had lower detection thresholds than 
did the solid medium, Herrold’s egg yolk. The BACTEC 12B medium was found to be the 
superior medium of the three with detection thresholds less than 10
2
 CFU/ml and the fastest 
time to detection. The optimal HPC decontamination protocol consisted of exposing milk to 
0.75% HPC for 5 hours at room temperature.  
Next, the efficacy of decontamination of milk with N-acetyl-L-cysteine-sodium 
hydroxide (NALC-NaOH) was explored. High concentrations of NaOH within the NALC-
NaOH solution and increased lengths of exposure did not affect the viability of MAP, though 
they did decrease the viability of contaminating microorganisms. Once again, BACTEC 12B 
medium had the lowest detection thresholds and fastest time to detection of the three media. 
The optimal NALC-NaOH decontamination protocol consisted of exposing milk to NALC-
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1.5% NaOH for 15 min. The optimal NALC-NaOH decontamination protocol also was found 
to be superior to the optimal HPC protocol, because it resulted in faster times to detection 
and lower detection thresholds. 
Because the NALC-NaOH decontamination protocol performed better in the 
optimization experiments and the first portion of the validation experiments than did the HPC 
decontamination protocol, it was chosen to be applied to milk samples collected from 7 dairy 
establishments across the US. The amount of sample contamination varied greatly between 
dairy establishments but was consistent between media. We hypothesized that the variation 
in levels of contamination are likely caused by inconsistent milking equipment cleaning 
procedures. Therefore, if care is taken to collect milk samples from properly cleaned milking 
equipment, the developed protocol is effective at controlling the growth of contaminating 
microorganisms while minimally affecting the viability of MAP.  
Once an efficacious decontamination protocol was developed, it would be applied to 
milk collected from complete 305-day lactation cycles of dairy cows affected by various 
stages of Johne’s disease. The results indicated there was a higher likelihood of MAP being 
isolated from milk in cows with advanced Johne’s disease. Also, MAP was more likely to be 
isolated in early lactation than in mid or late lactation. These findings have significant 
implications for dairy producers. We have demonstrated that the highest numbers of MAP 
are shed into the milk when the calf is most susceptible to infection. Therefore, any producer 
that allows the calf to suckle is risking transmission of MAP and dissemination of Johne’s 
disease throughout their herd, no matter how much care is taken to maintain clean maternity 
pens. We also have shown the importance of culling any cows with physical symptoms of 
Johne’s disease because they are likely to be shedding MAP into their milk. Therefore, if a 
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producer feeds bulk-raw milk or colostrum to calves, they could be transmitting MAP to 
calves born to cows not infected with MAP. 
This research has provided data to the dairy industry it desperately needs and will 
allow dairy producers to effectively control the transmission of MAP through milk. 
Hopefully, dairy producers will use this information to change their calf-rearing practices to 
minimize the chance of transmitting MAP to young stock in the herd and therefore be better 
able to control the prevalence of Johne’s disease. 
 
Recommendations for Future Research 
 Many avenues for research exist to further investigate the shedding of Mycobacterium 
avium subsp. paratuberculosis (MAP) into milk. Though many decontamination parameters 
were explored in this thesis, other chemicals and antibiotics may be less detrimental to MAP. 
Also, it would be efficacious to explore the use of other commercial or house-formulated 
media available for the culture of Mycobacterium spp. Increasing the volume of milk may 
also increase the chance of isolating MAP. Improvements in all of these parameters could 
lower the detection threshold of the assay even further.  
Another important factor to investigate is whether various isolates and strains possess 
equivalent abilities to resist cellular damage caused by the decontamination process. The 
information attained could be applied to a similar experiment evaluating shedding of MAP 
into the ovine and caprine milk and colostrum.  
A different method for detecting the presence of viable MAP in milk would be to 
develop an mRNA target. Efforts have been made to do this, though specificity and limits of 
detection have not reached sufficient levels to detect the low concentrations of MAP in milk.  
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Another topic of research that has not been thoroughly explored is how MAP 
disseminates from intestinal tissues throughout the body, especially to the mammary gland. 
Also, it is important to investigate whether ingestion of non-viable MAP or MAP fragments 
elicit an immune response, therefore causing false positive results on immune-based 
diagnostic tests.  
 All of this further research would aid in the general understanding of MAP infection 
and progression of Johne’s disease and would assist in achieving the ultimate goal of 
controlling the spread of and possibly eradicating Johne’s disease.
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APPENDIX 
 
Table A.1. Detailed results from the study investigating the efficacy of N-acetyl-L-cysteine-
sodium hydroxide decontamination of raw milk presented in chapter 4 
Herd 
Location 
Cow # Agea DIMb 
Culture: 
Fecal 
Direct 
PCR: 
Milkc 
Culture: Milk 
BACTEC 
12B 
para-JEM HEY 
S. Carolina 12 5 130 NDd ND ND  ND cont.e 
 15 5 325 ND ND  ND cont. cont. 
 417 8 50 ND ND  ND cont. ND 
 478 6 340 ND ND cont. cont. cont. 
 495 5 150 + ND cont. cont. cont. 
 497 5 365 ND ND cont. cont. cont. 
 503 5 390 ND ND  ND cont. cont. 
 505 5 130 ND ND non-MAPf non-MAP cont. 
 510 4 475 ND ND cont. cont. cont. 
 515 4 312 + ND ND  cont. ND 
 522 4 315 ND ND non-MAP cont. cont. 
 527 4 478 ND ND non-MAP cont. cont. 
 528 4 105 ND ND  ND cont. cont. 
 530 4 145 ND ND  ND ND ND 
 531 4 260 ND ND  ND cont. cont. 
 532 4 25 ND ND non-MAP ND cont. 
 537 3 125 ND ND  ND cont. ND 
 539 3 105 ND ND non-MAP cont. ND 
Ohiog 1 3 56 ND ND cont. ND ND 
 9 3 112 ND ND  ND ND ND 
 14 6 150 ND ND  ND ND ND 
 18 3 127 ND ND  ND ND ND 
 20 6 401 ND ND cont. ND cont. 
 25 6 262 ND ND  ND cont. ND 
 28 6 279 ND ND cont. ND ND 
 34 7 106 ND ND  ND cont. cont. 
 39 4 290 ND ND cont. cont. ND 
 40 6 152 + ND  ND ND cont. 
 42 4 198 ND ND  ND ND ND 
 43 4 460 ND ND  ND ND ND 
 45 7 319 ND ND  ND ND ND 
 48 4 272 ND ND cont. cont.  ND 
 57 3 74 ND ND  ND ND ND 
 65 7 124 ND ND cont. cont. ND 
 69 4 180 ND ND  ND cont. ND 
 77 4 269 ND ND  ND cont. ND 
 79 4 71 ND ND  ND cont. ND 
 80 3 101 ND ND  ND cont. ND 
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Table A.1. (continued) 
Herd 
Location 
Cow # Age DIM 
Culture: 
Fecal 
Direct 
PCR: 
Milk 
Culture: Milk 
BACTEC 
12B 
para-JEM HEY 
Michigan 1692 4 153 + + (39) cont. ND cont. 
 1709 4 84 + ND cont. ND cont. 
 1728 5 125 + ND cont. ND cont. 
 5311 6 146 + ND ND  ND cont. 
 5574 6 98 + ND  ND ND ND 
 5647 5 150 + ND cont. ND cont. 
 5911 5 60 + ND cont. ND ND 
 5930 5 107 ND ND cont.  ND cont 
 5984 4 235 ND ND cont. ND cont. 
 6014 4 79 ND ND non-MAP non-MAP cont. 
 6060 4 79 ND ND  ND ND ND 
 6065 4 124 + ND  ND cont. cont. 
 6141 4 195 ND ND non-MAP non-MAP cont. 
 6229 4 203 + ND + + cont.  
 6288 4 100 ND ND cont. ND cont. 
 6390 3 171 + ND  ND cont. cont. 
 6391 3 203 ND ND  ND ND cont. 
 6476 3 102 ND ND cont. ND ND 
 6522 3 99 ND ND  ND ND ND 
 6555 3 78 ND ND cont. ND ND 
Iowa A 6712 6 60 ND ND cont. ND ND 
 7415 4 59 ND ND cont. ND ND 
 7492 4 61 ND ND non-MAP ND ND 
 7544 4 70 ND ND cont. ND cont. 
 7604 3 115 ND ND non-MAP ND cont. 
 7728 3 88 ND ND non-MAP ND cont. 
 8012 2 169 ND ND  ND ND cont. 
 8027 2 150 ND ND non-MAP ND cont. 
 8051 2 177 ND ND  ND ND cont. 
 8053 2 172 ND ND  ND ND ND 
 8066 2 186 ND ND  ND ND cont. 
 8109 2 152 ND ND  ND ND cont. 
 8124 2 147 ND ND cont. ND ND 
 8132 2 79 ND ND cont. ND cont. 
 8135 2 94 ND ND cont. ND cont. 
 8137 2 82 ND ND  ND cont. cont. 
 8146 2 73 ND ND  ND ND cont. 
 8156 2 83 ND ND cont. cont. cont. 
 8182 2 43 ND ND cont. cont.  cont. 
 8210 2 50 ND ND cont. ND cont. 
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Table A.1. (continued) 
Herd 
Location 
Cow # Age DIM 
Culture: 
Fecal 
Direct 
PCR: 
Milk 
Culture: Milk 
BACTEC 
12B 
para-JEM HEY 
N. Dakota 2390 6 173 ND ND ND  ND ND 
 2395 6 350 ND ND  ND ND ND 
 2405 6 313 ND ND  ND ND ND 
 2427 6 287 ND ND cont. ND cont. 
 2444 5 195 + + (39)  ND ND cont. 
 2462 4 314 ND ND cont. ND ND 
 2464 4 63 + ND  ND ND ND 
 2491 4 173 + ND  ND ND ND 
 2494 4 221 ND + (40) cont. ND ND 
 2495 4 200 ND ND  ND ND ND 
 2500 3 45 ND ND  ND cont. ND 
 2501 3 180 + ND  ND cont. ND 
 2503 3 187 ND + (40)  ND ND ND 
 2506 3 205 ND ND  ND ND ND 
 2511 3 24 ND ND  ND ND ND 
 2512 3 83 ND ND  ND ND ND 
 2521 3 64 ND ND  ND cont. ND 
 2548 2 199 ND ND  ND ND ND 
 2563 2 44 ND ND  ND ND ND 
 2581 2 13 ND ND  ND ND ND 
Colorado 87 5 240 + ND ND  cont. ND 
 213 5 211 + + (38) cont. cont. cont. 
 217 5 394 ND ND  ND ND cont. 
 246 5 237 + ND cont. cont. ND 
 293 5 309 ND ND cont. ND cont. 
 430 4 169 ND ND cont. ND ND 
 432 4 390 + ND cont. ND ND 
 506 4 177 ND ND  ND cont. ND 
 904 3 182 ND ND cont. cont. cont. 
 945 3 400 ND ND cont. ND ND 
 950 3 495 ND ND  ND cont. cont. 
 997 3 480 ND ND non-MAP cont. ND 
 1008 3 453 ND ND non-MAP ND ND 
 1021 3 444 ND ND cont. cont. ND 
 1100 3 279 ND ND non-MAP cont. cont. 
 1139 2 291 ND ND non-MAP ND cont. 
 1263 2 124 ND ND  ND ND ND 
 2091 6 212 ND ND  ND cont. ND 
 2335 4 144 ND ND  ND ND ND 
 2417 3 220 ND + (37) non-MAP ND ND 
 3004 9 340 ND ND  ND cont. ND 
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Table A.1. (continued) 
Herd 
Location 
Cow # Age DIM 
Culture: 
Fecal 
Direct 
PCR: 
Milk 
Culture: Milk 
BACTEC 
12B 
para-JEM HEY 
Iowa B 53 9 61 ND + (38)  ND ND cont. 
 541 7 38 ND ND  ND ND cont. 
 651 6 326 + + (39)  ND cont. ND 
 786 5 684 + ND  ND cont. cont. 
 788 5 115 + + (38)  ND ND ND 
 789 6 117 + ND  ND ND ND 
 959 3 167 ND + (40)  ND ND ND 
 1009 3 152 ND ND  ND ND ND 
 1494 5 255 + ND  ND ND ND 
 1853 6 150 ND ND  ND ND ND 
 2222 7 454 + ND  ND ND cont. 
 2370 6 124 + ND  ND ND ND 
 2405 6 37 ND ND  ND cont. cont. 
 2444 5 272 + ND non-MAP non-MAP ND 
 2464 4 138 + ND  ND ND ND 
 2491 4 250 + + (39)  ND ND ND 
 2494 4 298 ND ND  ND ND ND 
 2668 4 273 ND + (38) + ND ND 
 3220 6 29 ND ND  ND ND ND 
 3318 6 50 ND ND  ND ND ND 
 3554 6 17 ND ND  ND ND ND 
 9514 3 22 ND ND  ND cont. ND 
 9614 3 292 + + (40)  ND ND ND 
 3039 6 305 ND ND  ND ND ND 
 3152 6 371 ND ND  ND ND cont. 
a
Cow age in years 
b
Days in milk 
c
Numbers in parenthesis are cycle threshold (Ct) values from real-time PCR 
d
The presence of Mycobacterium avium subsp. paratuberculosis not detected (ND) 
e
 Non-acid fast contaminate 
f
Acid-fast contaminate that is not Mycobacterium avium subsp. paratuberculosis 
g
Herd vaccinated for Mycobacterium avium subsp. paratuberculosis 
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Table A.2. Detailed results from the study of shedding of Mycobacterium avium subsp. 
paratuberculosis over a complete lactation from naturally infected dairy cows presented in 
chapter 5 
JD 
Status
a 
Year -
Cow # 
Age
b Sample 
Date 
DIM
c Direct 
PCR
d 
BACTEC 
12B 
Culture 
HEY 
Culture
e 
clinical 12-2222 7 4/12/2012 1 + (38.9) ND
f 
ND 
      4/14/2012 3 + (39.3) ND cont.
g 
      4/18/2012 7 + (38.5) ND ND 
      4/25/2012 14 ND ND ND 
      5/10/2012 29 ND ND ND 
      7/2/2012 82 ND ND ND 
clinical 11-788 4 12/23/2011 1 ND ND ND 
      12/25/2011 3 ND ND ND 
      12/29/2011 7 ND ND ND 
      1/5/2012 14 + (41.7) ND ND 
      1/12/2012 21 ND cont. ND 
      1/19/2012 28 ND ND ND 
      3/7/2012 76 ND ND ND 
      6/5/2012 166 ND ND ND 
clinical 11-789 4 12/21/2011 1 ND cont. ND 
      12/23/2011 3 ND ND ND 
      12/27/2011 7 ND ND ND 
      1/3/2012 14 ND ND ND 
      1/10/2012 21 ND ND ND 
      1/17/2012 28 ND ND ND 
      3/7/2012 78 ND ND ND 
      6/5/2012 168 ND ND ND 
clinical 11-1442 6 7/18/2011 1 + (40.6) ND ND 
      7/20/2011 3 + (40.6) ND ND 
      7/24/2011 7 ND ND ND 
      7/31/2011 14 ND ND ND 
      8/6/2011 20 ND cont. ND 
      8/20/2011 34 ND ND ND 
      8/28/2011 42 ND ND ND 
      10/4/2011 79 + (40.2) ND ND 
clinical 11-1445 6 11/7/2011 1 + (36.2) + + 
      11/9/2011 3 + (38.5) + + 
      11/13/2011 7 + (38.0) + ND 
      11/20/2011 14 + (30.1) + + 
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Table A.2. (continued) 
JD 
Status 
Year -
Cow # 
Age 
Sample 
Date 
DIM 
Direct 
PCR 
BACTEC 
12B 
Culture 
HEY 
Culture 
clinical 11-2668 3 7/18/2011 1 ND ND ND 
      7/20/2011 3 ND ND ND 
      7/24/2011 7 ND ND ND 
      7/31/2011 14 ND ND ND 
      8/7/2011 21 + (39.7) + ND 
      8/28/2011 42 ND ND ND 
      10/4/2011 79 + (39.6) ND ND 
      1/3/2012 170 + (38.1) ND ND 
      5/10/2012 298 ND ND ND 
clinical 10-786 4 6/2/2010 1 ND ND ND 
      6/4/2010 3 ND cont. ND 
      6/8/2010 7 ND ND ND 
      6/15/2010 14 ND cont. ND 
      6/22/2010 21 ND ND ND 
      6/29/2010 28 ND ND ND 
      8/26/2010 86 ND cont. ND 
      11/22/2010 174 + (39.9) ND ND 
      3/24/2011 296 ND ND ND 
clinical 10-2324 5 4/12/2010 1 ND ND ND 
      4/14/2010 3 ND ND ND 
      4/17/2010 6 ND ND ND 
      4/25/2010 14 ND ND ND 
clinical 08-41 3 10/19/2008 1 ND ND ND 
      10/22/2008 4 ND cont. ND 
      10/25/2008 7 ND ND ND 
      11/1/2008 14 ND ND ND 
      11/8/2008 21 ND ND ND 
      11/15/2008 28 ND ND ND 
clinical 07-6551 4 11/7/2007 1 + (39.7) + + 
      11/8/2007 2 + (39.7) ND ND 
      11/21/2007 15 + (39.5) ND + 
      11/26/2007 20 + (38.9) ND ND 
clinical 06-183 9 3/16/2006 1 ND ND ND 
      3/18/2006 3 ND ND cont. 
      3/23/2006 8 ND ND ND 
      3/29/2006 14 ND ND cont. 
      4/5/2006 21 + (40.3) ND ND 
 
141 
 
 
Table A.2. (continued) 
JD 
Status 
Year -
Cow # 
Age 
Sample 
Date 
DIM 
Direct 
PCR 
BACTEC 
12B 
Culture 
HEY 
Culture 
clinical 06-312 unk
h 
5/8/2006 1 + (37.5) cont. cont. 
      5/10/2006 3 + (36.5) ND ND 
      5/13/2006 6 + (34.9) cont. cont. 
      5/28/2006 21 + (34.6) cont. cont. 
clinical 06-952 4 3/16/2006 2 ND ND ND 
      3/17/2006 3 ND ND ND 
      3/19/2006 5 ND ND cont. 
      4/4/2006 21 ND ND ND 
clinical 06-1433 unk 5/10/2006 1 + (37.7) ND ND 
      5/12/2006 3 + (35.9) + + 
      5/16/2006 7 + (31.5) + + 
      5/29/2006 20 + (34.7) cont. cont. 
clinical 06-1657 unk 7/10/2006 1 + (38.0) ND cont. 
      7/11/2006 2 + (36.9) + ND 
      7/16/2006 7 + (38.8) ND ND 
      7/23/2006 14 + (38.9) cont. cont. 
      7/30/2006 21 + (39.0) ND cont. 
      8/6/2006 28 ND ND ND 
clinical 06-3494 5 4/15/2006 2 ND ND ND 
      4/16/2006 3 ND + + 
      4/18/2006 5 ND ND cont. 
      4/26/2006 13 + (39.3) ND ND 
      5/4/2006 21 + (36.2) ND ND 
      5/11/2006 28 + (40.0) cont. cont. 
clinical 06-5391 unk 5/7/2006 1 + (32.8) + + 
      5/9/2006 3 + (37.2) + + 
      5/13/2006 7 + (35.9) ND + 
      5/27/2006 21 + (38.5) ND ND 
clinical 06-6278 unk 5/16/2006 1 + (38.4) ND cont. 
      5/18/2006 3 + (38.4) + ND 
      5/29/2006 14 + (39.9) ND ND 
      6/5/2006 21 + (39.3) ND ND 
      6/12/2006 28 ND ND ND 
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Table A.2. (continued) 
JD 
Status 
Year -
Cow # 
Age 
Sample 
Date 
DIM 
Direct 
PCR 
BACTEC 
12B 
Culture 
HEY 
Culture 
clinical 05-2075 6 4/20/2005 1 ND ND ND 
      4/22/2005 3 ND ND ND 
      4/27/2005 8 ND ND ND 
      5/4/2005 15 + (41.4) ND ND 
      5/11/2005 22 ND ND cont. 
      5/18/2005 29 ND ND cont. 
clinical 05-3494 4 1/30/2005 1 ND ND ND 
      2/1/2005 3 ND ND ND 
      2/6/2005 8 ND ND ND 
      2/13/2005 15 ND ND ND 
      2/20/2005 22 ND ND ND 
      2/27/2005 29 ND ND ND 
sub 12-53 9 2/15/2012 1 ND ND ND 
      2/17/2012 3 ND ND ND 
      2/21/2012 7 ND ND ND 
      2/28/2012 14 ND ND ND 
      3/6/2012 21 ND ND ND 
      3/13/2012 28 ND ND ND 
      5/10/2012 86 ND ND ND 
sub 11-651 5 5/26/2011 1 ND ND ND 
      5/27/2011 2 ND ND ND 
      5/30/2011 5 ND ND ND 
      6/8/2011 14 ND ND ND 
      6/15/2011 21 ND ND ND 
      6/22/2011 28 ND ND cont. 
      8/28/2011 95 ND ND ND 
      11/21/2011 180 + (38.9) + + 
      4/3/2012 314 ND ND ND 
sub 11-790 4 5/23/2011 2 ND ND ND 
      5/24/2011 3 ND ND ND 
      6/30/2011 40 ND ND ND 
      8/28/2011 99 ND ND ND 
      11/21/2011 184 ND ND ND 
      1/29/2012 253 + (37.9) ND ND 
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Table A.2. (continued) 
JD 
Status 
Year -
Cow # 
Age 
Sample 
Date 
DIM 
Direct 
PCR 
BACTEC 
12B 
Culture 
HEY 
Culture 
sub 11-959 2 11/1/2011 1 ND ND ND 
      11/3/2011 3 ND ND ND 
      11/7/2011 7 ND ND ND 
      11/14/2011 14 ND ND ND 
      11/21/2011 21 ND ND ND 
      11/28/2011 28 ND ND ND 
      1/30/2012 91 + (39.6) ND ND 
      5/10/2012 192 ND ND ND 
      7/2/2012 245 ND ND ND 
sub 11-1009 2 11/16/2011 1 + (38.9) + + 
      11/18/2011 3 + (36.1) + ND 
      11/22/2011 7 + (39.7) + ND 
      11/29/2011 14 ND ND ND 
      12/6/2011 21 ND ND ND 
      12/13/2011 28 ND ND ND 
      1/29/2012 75 ND ND ND 
      5/10/2012 177 ND ND ND 
      7/2/2012 230 ND ND ND 
sub 11-2222 6 1/19/2011 2 ND ND ND 
      1/20/2011 3 ND ND cont. 
      1/23/2011 6 ND ND ND 
      1/31/2011 14 + (40.7) ND ND 
      2/7/2011 21 ND ND ND 
      2/14/2011 28 ND ND cont. 
      4/20/2011 93 ND ND ND 
      6/30/2011 164 ND ND ND 
      11/21/2011 308 + (40.9) ND ND 
sub 11-2370 5 12/14/2011 1 ND ND ND 
      12/17/2011 4 ND ND ND 
      12/20/2011 7 ND ND ND 
      12/27/2011 14 ND ND ND 
      1/3/2012 21 + (39.9) ND ND 
      1/10/2012 28 ND ND ND 
      3/7/2012 85 ND ND ND 
      6/5/2012 175 ND ND ND 
 
 
 
144 
 
 
Table A.2. (continued) 
JD 
Status 
Year -
Cow # 
Age 
Sample 
Date 
DIM 
Direct 
PCR 
BACTEC 
12B 
Culture 
HEY 
Culture 
sub 11-3135 9 6/22/2011 2 ND non-MAP cont. 
      6/23/2011 3 ND ND ND 
      6/27/2011 7 ND ND ND 
      7/4/2011 14 ND ND ND 
      7/11/2011 21 ND ND ND 
      7/18/2011 28 ND ND ND 
      10/4/2011 106 ND ND ND 
      1/3/2012 197 ND ND ND 
      3/7/2012 261 ND ND ND 
sub 10-76 6 6/8/2010 2 ND ND ND 
      6/9/2010 3 ND ND ND 
      6/13/2010 7 ND ND ND 
      6/26/2010 20 ND ND ND 
      7/5/2010 29 ND ND ND 
      8/31/2010 86 ND ND ND 
      11/25/2010 172 ND ND ND 
      2/22/2011 261 + (39.4) ND ND 
sub 10-82 6 11/21/2010 2 ND ND cont. 
      11/22/2010 3 ND ND cont. 
      11/26/2010 7 ND ND cont. 
      11/30/2010 11 ND ND cont. 
      12/10/2010 21 ND cont. cont. 
      12/18/2010 29 ND ND ND 
      2/13/2011 86 ND ND cont. 
      5/25/2011 187 ND ND ND 
sub 10-532 5 7/26/2010 1 ND ND ND 
      7/28/2010 3 ND ND ND 
      8/1/2010 7 ND ND ND 
      8/8/2010 14 ND ND ND 
      8/15/2010 21 ND ND ND 
      8/22/2010 28 ND ND ND 
      10/18/2010 85 + (40.2) ND ND 
      1/12/2011 171 ND ND cont. 
      4/20/2011 269 ND ND ND 
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Table A.2. (continued) 
JD 
Status 
Year -
Cow # 
Age 
Sample 
Date 
DIM 
Direct 
PCR 
BACTEC 
12B 
Culture 
HEY 
Culture 
sub 10-533 5 7/12/2010 1 ND ND cont. 
      7/14/2010 3 ND ND ND 
      7/18/2010 7 ND ND ND 
      8/1/2010 21 ND ND ND 
      8/6/2010 26 ND ND cont. 
      10/4/2010 85 ND ND ND 
      12/30/2010 172 ND ND ND 
      5/25/2011 318 ND ND ND 
sub 10-648 4 9/1/2010 1 ND + cont. 
      9/3/2010 3 ND ND ND 
      9/8/2010 8 ND ND cont. 
      9/15/2010 15 ND ND cont. 
      9/22/2010 22 ND ND ND 
      9/29/2010 29 ND ND cont. 
      11/25/2010 86 ND cont. ND 
      2/20/2011 173 ND ND ND 
      6/30/2011 303 ND ND ND 
sub 10-788 3 7/29/2010 1 ND ND ND 
      7/31/2010 3 ND ND ND 
      8/4/2010 7 ND ND ND 
      8/11/2010 14 ND cont. ND 
      8/18/2010 21 ND ND ND 
      8/25/2010 28 ND ND ND 
      10/23/2010 87 ND ND cont. 
      2/17/2011 204 ND ND ND 
      5/25/2011 301 ND ND ND 
sub 10-789 3 10/19/2010 1 ND ND ND 
      10/21/2010 3 ND ND cont. 
      10/25/2010 7 + (35.0) cont. cont. 
      11/1/2010 14 ND ND cont. 
      11/8/2010 21 ND ND ND 
      11/15/2010 28 ND ND ND 
      1/21/2011 95 ND ND ND 
      4/20/2011 184 ND ND ND 
      8/28/2011 314 ND ND ND 
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Table A.2. (continued) 
JD 
Status 
Year -
Cow # 
Age 
Sample 
Date 
DIM 
Direct 
PCR 
BACTEC 
12B 
Culture 
HEY 
Culture 
sub 10-791 3 10/25/2010 1 ND ND cont. 
      10/27/2010 3 ND ND ND 
      10/31/2010 7 ND ND ND 
      11/14/2010 21 ND ND ND 
      11/21/2010 28 ND ND ND 
      12/20/2010 57 ND ND ND 
sub 10-1459 ukn 11/15/2010 3 ND ND ND 
      11/19/2010 7 ND ND cont. 
      11/26/2010 14 ND ND ND 
      12/3/2010 21 ND ND ND 
      12/11/2010 29 ND ND ND 
      2/5/2011 85 ND ND ND 
      5/25/2011 194 ND ND ND 
      9/20/2011 312 ND cont. ND 
sub 10-2370 4 8/2/2010 3 ND ND ND 
      8/4/2010 5 ND ND ND 
      8/8/2010 9 ND ND ND 
      8/15/2010 16 ND ND ND 
      8/22/2010 23 ND ND ND 
      8/29/2010 30 + (41.7) ND ND 
      10/26/2010 88 ND ND ND 
      1/19/2011 173 ND ND ND 
      5/25/2011 299 ND ND ND 
sub 09-89 6 6/19/2009 1 ND ND ND 
      6/20/2009 2 ND ND ND 
      6/25/2009 7 ND ND ND 
      7/2/2009 14 ND ND ND 
      7/9/2009 21 ND ND ND 
      7/16/2009 28 ND ND ND 
sub 09-532 4 6/15/2009 1 ND ND ND 
      6/16/2009 2 ND ND ND 
      6/21/2009 7 ND ND ND 
      6/28/2009 14 ND ND ND 
      7/5/2009 21 ND ND ND 
      7/12/2009 28 ND ND ND 
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Table A.2. (continued) 
JD 
Status 
Year -
Cow # 
Age 
Sample 
Date 
DIM 
Direct 
PCR 
BACTEC 
12B 
Culture 
HEY 
Culture 
sub 09-648 3 6/25/2009 1 ND ND ND 
      6/26/2009 2 ND ND ND 
      7/1/2009 7 ND ND ND 
      7/8/2009 14 ND ND ND 
      7/15/2009 21 ND ND ND 
      7/22/2009 28 ND ND ND 
sub 08-540 3 9/21/2008 1 ND ND ND 
      9/22/2008 2 ND ND ND 
      9/27/2008 7 ND ND ND 
      10/4/2008 14 ND ND ND 
      10/11/2008 21 ND ND ND 
      10/18/2008 28 ND ND ND 
sub 08-647 2 9/12/2008 1 ND ND ND 
      9/13/2008 2 ND ND ND 
      9/19/2008 8 ND ND cont. 
      9/26/2008 15 + (39.2) ND ND 
      10/3/2008 22 ND ND ND 
      10/10/2008 29 ND ND ND 
sub 08-1145 6 9/21/2008 1 ND ND ND 
      9/22/2008 2 ND ND ND 
      9/27/2008 7 ND ND ND 
      10/4/2008 14 ND ND ND 
      10/11/2008 21 ND ND ND 
      10/18/2008 28 ND ND ND 
control 11-810 3 7/20/2011 1 ND ND ND 
      7/22/2011 3 ND ND cont. 
      7/26/2011 7 ND ND cont. 
control 10-459 6 8/2/2010 1 ND ND cont. 
      8/4/2010 3 ND cont. cont. 
      8/8/2010 7 ND ND cont. 
      8/15/2010 14 ND ND cont. 
      8/22/2010 21 ND ND cont. 
      8/29/2010 28 ND cont. cont. 
      10/26/2010 86 ND ND ND 
      2/21/2011 204 ND ND ND 
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Table A.2. (continued) 
JD 
Status 
Year -
Cow # 
Age 
Sample 
Date 
DIM 
Direct 
PCR 
BACTEC 
12B 
Culture 
HEY 
Culture 
control 10-781 3 10/9/2010 1 ND ND ND 
      10/11/2010 3 ND non-MAP cont. 
      10/15/2010 7 ND ND ND 
      10/22/2010 14 ND ND ND 
      10/29/2010 21 ND ND ND 
      11/5/2010 28 ND ND ND 
      1/3/2011 87 ND cont. ND 
      4/1/2011 175 ND ND ND 
      8/28/2011 324 ND ND cont. 
control 10-782 3 12/30/2010 1 ND cont. cont. 
      1/1/2011 3 ND ND cont. 
      1/5/2011 7 ND ND ND 
      1/12/2011 14 ND ND ND 
      1/26/2011 28 ND ND ND 
      3/27/2011 88 ND ND cont. 
      7/11/2011 194 ND ND cont. 
      11/9/2011 315 ND ND cont. 
control 10-785 3 9/21/2010 1 ND ND ND 
      9/22/2010 2 ND ND cont. 
      9/27/2010 7 ND ND ND 
      10/4/2010 14 ND ND ND 
      10/11/2010 21 ND ND cont. 
      10/18/2010 28 ND ND ND 
      1/3/2011 105 ND cont. ND 
      4/10/2011 202 ND ND ND 
      8/28/2011 342 ND ND ND 
control 08-459 4 1/21/2008 1 ND ND ND 
      1/22/2008 2 ND ND ND 
      1/27/2008 7 ND ND ND 
      2/3/2008 14 ND ND ND 
      2/10/2008 21 ND ND ND 
      2/17/2008 28 ND ND ND 
aJohne’s disease status; clinical, subclinical, and control or non-infected 
b
Approximate cow age in years at the beginning of lactation 
c
Days in milk 
d
Numbers in parenthesis are cycle threshold (Ct) values from real-time PCR 
eHerrold’s egg yolk medium 
f
The presence of Mycobacterium avium subsp. paratuberculosis not detected (ND) 
g
 Non-acid fast contaminate 
